RESULT_COUNT: 365,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Supports 2017 World Thrombosis Day Campaign to Raise Awareness about the Persistent Risk of Blood Clots,2017-10-11 20:05:00 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-supports-2017-world-200500844.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Oct. 11, 2017-- Portola Pharmaceuticals Inc. ® announced today that it will be serving as a global partner for World Thrombosis Day to help raise awareness of the incidence, ..."
PTLA,PTLA:UW,BBG004FJG6B0,See what the IHS Markit Score report has to say about Portola Pharmaceuticals Inc.,2017-10-09 12:05:05 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120505265.html?.tsrc=rss,"Short interest is low for PTLA with fewer than 5% of shares on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last month, ETFs holding PTLA are favorable, with net inflows of $3.75 billion."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),2017-10-03 20:05:00 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-reports-inducement-grants-200500729.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Oct. 03, 2017-- Portola Pharmaceuticals, Inc. ® announced today that on September 27, 2017, the Compensation Committee of the Board of Directors approved, effective as of September ..."
PTLA,PTLA:UW,BBG004FJG6B0,See what the IHS Markit Score report has to say about Portola Pharmaceuticals Inc.,2017-10-02 12:02:07 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120432731.html?.tsrc=rss,Short interest is low for PTLA with fewer than 5% of shares on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
PTLA,PTLA:UW,BBG004FJG6B0,Cramer's lightning round: Portola's no one-trick pony,2017-09-26 22:58:00 +0000,https://finance.yahoo.com/video/cramers-lightning-round-portolas-no-225800052.html?.tsrc=rss,"Jim Cramer flies through his take on callers' favorite stocks at lightning speed, including one pharmaceutical name."
PTLA,PTLA:UW,BBG004FJG6B0,See what the IHS Markit Score report has to say about Portola Pharmaceuticals Inc.,2017-09-26 12:05:08 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120508079.html?.tsrc=rss,Short interest is low for PTLA with fewer than 5% of shares on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
PTLA,PTLA:UW,BBG004FJG6B0,Analysts Expect JKK To Hit $183,2017-09-20 14:37:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RbheUA3Drn8/analysts-expect-jkk-to-hit-183-cm848283,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
PTLA,PTLA:UW,BBG004FJG6B0,Today's Research Reports on Trending Tickers: Portola Pharmaceuticals and Synchronoss Technologies,2017-09-20 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000129.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 20, 2017 / All of the major indexes reached new record highs on Tuesday as Federal Reserve policymakers kicked off their two-day policy meeting. The Dow Jones Industrial ..."
PTLA,PTLA:UW,BBG004FJG6B0,Is It The Right Time To Buy Portola Pharmaceuticals Inc (PTLA)?,2017-09-19 13:39:10 +0000,https://finance.yahoo.com/news/time-buy-portola-pharmaceuticals-inc-133910128.html?.tsrc=rss,"Portola Pharmaceuticals Inc (NASDAQ:PTLA), a pharmaceuticals, biotechnology and life sciences company based in United States, saw a significant share price rise of over 20% in the past couple of monthsRead More..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Shares Lower After Pricing Stock Offering - Biotech Movers,2017-09-13 13:06:00 +0000,http://finance.yahoo.com/r/d91b9842-2e40-3ac3-83b1-a60fdd638d61/portola-shares-lower-after-pricing-stock-offering-biotech-movers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The South San Francisco, Calif.-based firm said Sept. 12 it had priced its underwritten public offering of 6.35 million shares at $55 apiece."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Prices Offering At $55/Share,2017-09-13 07:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qjI-JSJeVqQ/portola-prices-offering-at-55share-20170913-00305,Portola Prices Offering At $55/Share
PTLA,PTLA:UW,BBG004FJG6B0,Portola Announces Pricing of Public Offering of Common Stock,2017-09-13 02:39:17 +0000,https://finance.yahoo.com/news/portola-announces-pricing-public-offering-023917543.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Sept. 12, 2017-- Portola Pharmaceuticals, Inc. announced today the pricing of its underwritten public offering of 6,350,000 shares of its common stock at a price to the public ..."
PTLA,PTLA:UW,BBG004FJG6B0,See what the IHS Markit Score report has to say about Portola Pharmaceuticals Inc.,2017-09-12 12:04:32 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120432692.html?.tsrc=rss,Short interest is low for PTLA with fewer than 5% of shares on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Proposed Offering of Common Stock,2017-09-11 20:01:00 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-announces-proposed-offering-200100147.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Sept. 11, 2017-- Portola Pharmaceuticals, Inc. ® today announced plans to offer, subject to market and other conditions, $300 million of its common stock in an underwritten ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Glancy Prongay & Murray LLP Commences Investigation on Behalf of Portola Pharmaceuticals, Inc. Investors (PTLA)",2017-09-07 18:10:00 +0000,https://finance.yahoo.com/news/glancy-prongay-murray-llp-commences-181000468.html?.tsrc=rss,"Glancy Prongay & Murray LLP announces an investigation on behalf of Portola Pharmaceuticals, Inc. investors concerning the Company and its officers’ possible violations of federal securities laws."
PTLA,PTLA:UW,BBG004FJG6B0,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Portola Pharmaceuticals, Inc.",2017-09-06 21:46:00 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-214600066.html?.tsrc=rss,"Levi & Korsinsky announces it has commenced an investigation of Portola Pharmaceuticals, Inc. concerning possible violations of federal securities laws."
PTLA,PTLA:UW,BBG004FJG6B0,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Portola Pharmaceuticals Inc. (PTLA)",2017-09-06 20:01:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-200100918.html?.tsrc=rss,"NEW YORK , Sept. 6, 2017 /PRNewswire/ -- Attorney Advertising - Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Portola Pharmaceuticals Inc. (""Portola"" ..."
PTLA,PTLA:UW,BBG004FJG6B0,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA,2017-09-06 18:04:00 +0000,https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-180400614.html?.tsrc=rss,"NEW YORK, September  6, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Portola Pharmaceuticals Inc. (""Portola"" or the ""Company"") (NASDAQ: PTLA).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.  On this news, Portola's share price has fallen as much as $3.83, or 6.44%, during intraday trading on September 6, 2017."
PTLA,PTLA:UW,BBG004FJG6B0,Today's Research Reports on Trending Tickers: Pulmatrix Inc. and Portola Pharmaceuticals Inc.,2017-09-06 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000413.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 6, 2017 / U.S. markets tumbled Tuesday as escalating geopolitical tensions between North Korea and the U.S. weighed down Wall Street. On Sunday, North Korea completed ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals to Present at the 2017 Morgan Stanley Global Healthcare Conference,2017-09-06 12:00:00 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-present-2017-morgan-120000799.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Sept. 06, 2017-- Portola Pharmaceuticals today announced that Bill Lis, chief executive officer, will present at the 2017 Morgan Stanley Global Healthcare Conference on Wednesday, ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Reminder: Portola Pharmaceuticals to Host Webcast and Conference Call Today, Tuesday, Sept. 5 to Provide Further Details on Bevyxxa® (betrixaban) Launch",2017-09-05 12:00:00 +0000,https://finance.yahoo.com/news/reminder-portola-pharmaceuticals-host-webcast-120000445.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Sept. 05, 2017-- Portola Pharmaceuticals announced that it will host a webcast and conference call to provide an update on Bevyxxa ® launch plans, the validation of the commercial ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Host Webcast and Conference Call Tuesday, Sept. 5 to Provide Further Details on Bevyxxa® (betrixaban) Launch",2017-09-01 22:34:46 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-host-webcast-conference-223446670.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Sept. 01, 2017-- Portola Pharmaceuticals announced that it will host a webcast and conference call to provide an update on Bevyxxa ® launch plans, the validation of the commercial ..."
PTLA,PTLA:UW,BBG004FJG6B0,Pfizer Presents Encouraging Eliquis Results in NVAF Patients,2017-08-29 17:51:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u_CNTXBbgbw/pfizer-presents-encouraging-eliquis-results-in-nvaf-patients-cm838728,Pfizer Inc PFE and partner Bristol Myers Squibb Company BMY presented findings from a phase IV study on Eliquis which demonstrated the oral anticoagulation s potential in achieving and maintaining normal heart rhythm cardioversion The study EMANATE compared Eliquis with standard of
PTLA,PTLA:UW,BBG004FJG6B0,"ETFs with exposure to Portola Pharmaceuticals, Inc. : August 25, 2017",2017-08-25 21:17:26 +0000,http://finance.yahoo.com/r/f88cb428-b45b-38d6-8f72-62fd7789c8ed/etfs-with-exposure-to-portola-pharmaceuticals-inc-august-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Portola Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PTLA-US. Comparing the performance and risk of Portola Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,"[$$] Down With Teva, Up With Portola",2017-08-25 15:03:00 +0000,http://finance.yahoo.com/r/6bc072d8-ca41-30d8-a1c9-8f3db749bb3f/down-with-teva-up-with-portola-1503673394?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  Ahead of an expected uptick in pharmaceuticals news flow next month, we make several rating and target price changes as we look towards year-end 2017 and first-half 2018.  Conversely, we upgrade Portola Pharmaceuticals (PTLA) to Outperform from Neutral, while maintaining our $70 target price ahead of the Bevyxxa launch and likely AndexXa approval, and upgrade Corvus Pharmaceuticals (CRVS) to Neutral from Underperform, and increase our target price to $14 from $12 ahead of additional CPI-444 data at SITC."
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PTLA-US : August 25, 2017",2017-08-25 12:41:06 +0000,http://finance.yahoo.com/r/0fe78bec-f8f4-370e-988f-50699c440359/portola-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-ptla-us-august-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Portola Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,"Today's Research Reports on Trending Tickers: Portola Pharmaceuticals Inc. and Neurocrine Biosciences, Inc.",2017-08-25 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000770.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 25, 2017 / U.S. markets closed in the red Thursday as investors await comments on monetary policy from the annual meeting of central bankers in Jackson Hole, Wyoming. ..."
PTLA,PTLA:UW,BBG004FJG6B0,See what the IHS Markit Score report has to say about Portola Pharmaceuticals Inc.,2017-08-23 12:04:15 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120415714.html?.tsrc=rss,"Short interest is low for PTLA with fewer than 5% of shares on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last month, ETFs holding PTLA are favorable, with net inflows of $2.88 billion."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and Andexanet Alfa at the European Society of Cardiology (ESC) Congress 2017,2017-08-21 12:00:00 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-announces-upcoming-data-120000226.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Aug. 21, 2017-- Portola Pharmaceuticals Inc. ® today announced that data on betrixaban and andexanet alfa, as well as presentations on disease awareness and risk, will be presented ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Becomes Oversold (PTLA),2017-08-17 20:42:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d2RhnNNCUSY/portola-pharmaceuticals-becomes-oversold-ptla-cm833608,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
PTLA,PTLA:UW,BBG004FJG6B0,FDA Accepts Portola's (PTLA) BLA Resubmission for AndexXa,2017-08-17 16:39:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sIIqu04cmSo/fda-accepts-portolas-ptla-bla-resubmission-for-andexxa-cm833384,Portola Pharmaceuticals Inc PTLA recently announced that the FDA has accepted its resubmitted biologics license application BLA for the reversal agent for Factor Xa inhibitors AndexXa Andexanet Alfa A decision from the U S regulatory body is expected on Feb 2 2018 AndexXa has
PTLA,PTLA:UW,BBG004FJG6B0,FDA Accepts Portola&apos;s (PTLA) BLA Resubmission for AndexXa,2017-08-17 14:22:02 +0000,https://finance.yahoo.com/news/fda-accepts-portola-apos-ptla-142202165.html?.tsrc=rss,FDA acknowledges Portola&apos;s (PTLA) resubmitted BLA for AndexXa to raise hopes for an urgent need of antidotes for Factor Xa inhibitors in the market.
PTLA,PTLA:UW,BBG004FJG6B0,Featured Company News - Portola Pharmaceuticals' AndexXa(R) Biologics License Application Resubmission Accepted for Review by US FDA,2017-08-17 11:40:00 +0000,https://finance.yahoo.com/news/featured-company-news-portola-pharmaceuticals-114000882.html?.tsrc=rss,"Research Desk Line-up: Alnylam Pharma Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 17, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Portola ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. :PTLA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017",2017-08-16 14:49:18 +0000,http://finance.yahoo.com/r/304d4519-6515-3e10-8de6-600af1272bef/portola-pharmaceuticals-inc-ptla-us-earnings-analysis-q2-2017-by-the-numbers-august-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Portola Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Portola Pharmaceuticals, Inc. – Johnson & Johnson, Biogen Inc., Bristol-Myers Squibb Company, Pfizer Inc. and Sanofi Sponsored ADR (JNJ-US, BIIB-US, BMY-US, PFE-US and SNY-US) that have also reported ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges",2017-08-16 02:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UPeOCxT4xeY/alxns-strengthening-patents-folds-fabry-drug-approved-in-oz-vbiv-surges-20170816-00044,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges"
PTLA,PTLA:UW,BBG004FJG6B0,Health Care Sector Update for 08/15/2017: PTLA,2017-08-15 13:55:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7vvbvNUCh6E/health-care-sector-update-for-08152017-ptla-cm832141,Top Health care stocks Top Health care stocks JNJ 0 1 JNJ 0 1 PFE flatPFE flat ABT flatABT flat MRK 0 1 MRK 0 1 AMGN flatAMGN flat Health care shares were mainly unchanged in pre market trade on Tuesday Health care shares were mainly unchanged in pre market trade on Tuesday
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces AndexXa® (Andexanet Alfa) Biologics License Application Resubmission Accepted for Review by U.S. FDA,2017-08-15 12:00:00 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-announces-andexxa-andexanet-120000017.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Aug. 15, 2017-- Portola Pharmaceuticals Inc. ® today announced that the U.S. Food and Drug Administration has found its resubmitted Biologics License Application for AndexXa ..."
PTLA,PTLA:UW,BBG004FJG6B0,Implied VTWO Analyst Target Price: $121,2017-08-14 14:36:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yGbxUcDg7YE/implied-vtwo-analyst-target-price-121-cm831563,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
PTLA,PTLA:UW,BBG004FJG6B0,Edited Transcript of PTLA earnings conference call or presentation 9-Aug-17 8:30pm GMT,2017-08-13 14:05:50 +0000,https://finance.yahoo.com/news/edited-transcript-ptla-earnings-conference-042604101.html?.tsrc=rss,Q2 2017 Portola Pharmaceuticals Inc Earnings Call
PTLA,PTLA:UW,BBG004FJG6B0,See what the IHS Markit Score report has to say about Portola Pharmaceuticals Inc.,2017-08-12 12:05:33 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120533331.html?.tsrc=rss,"Short interest is low for PTLA with fewer than 5% of shares on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last one-month, outflows of investor capital in ETFs holding PTLA totaled $148 million."
PTLA,PTLA:UW,BBG004FJG6B0,Today's Research Reports on Stocks to Watch: Portola Pharmaceuticals and BioDelivery Sciences International,2017-08-11 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000619.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 11, 2017 / Both BioDelivery Sciences and Portola Pharmaceuticals failed to meet Wall Street's views when they released their second quarter financial results. Despite ..."
PTLA,PTLA:UW,BBG004FJG6B0,These Biotech Stocks are BOOMING,2017-08-10 14:01:00 +0000,http://finance.yahoo.com/r/2bd1acc7-164c-3ebe-ba6d-cd07f4481265/biotech-movers-perrigo-jumps-after-raising-adjusted-eps-outlook.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Perrigo leading the charge.
PTLA,PTLA:UW,BBG004FJG6B0,"IHS Markit Score downgrades Portola Pharmaceuticals Inc to 30 out of 100, ranking positively in only one out of three available IHS Markit categories.",2017-08-10 12:05:55 +0000,https://finance.yahoo.com/news/ihs-markit-score-downgrades-portola-120555011.html?.tsrc=rss,"Short interest is low for PTLA with fewer than 5% of shares on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last one-month, outflows of investor capital in ETFs holding PTLA totaled $498 million."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals posts 2Q loss,2017-08-10 04:33:48 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-posts-2q-loss-213025482.html?.tsrc=rss,"On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.22. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update,2017-08-09 20:25:00 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-reports-second-quarter-202500088.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Aug. 09, 2017-- Portola Pharmaceuticals Inc. ® today reported financial results and provided a corporate update for the quarter ended June 30, 2017.. “FDA approval of our first ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Investor Network: Portola Pharmaceuticals, Inc. to Host Earnings Call",2017-08-09 17:00:00 +0000,https://finance.yahoo.com/news/investor-network-portola-pharmaceuticals-inc-170000686.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Portola Pharmaceuticals, Inc. (NASDAQ: PTLA ) will be discussing their earnings results in their Q2 Earnings Call to be held on Wednesday, August 9, 2017 at ..."
PTLA,PTLA:UW,BBG004FJG6B0,"DVAX Plunges On Delay In Approval, FDA Nod For ABBV's HCV Drug, ABIO On Radar",2017-08-04 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5id7u3diVtI/dvax-plunges-on-delay-in-approval-fda-nod-for-abbvs-hcv-drug-abio-on-radar-20170804-00064,"DVAX Plunges On Delay In Approval, FDA Nod For ABBV's HCV Drug, ABIO On Radar"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Resubmission of Biologics License Application for AndexXa® (Andexanet Alfa),2017-08-03 20:13:30 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-announces-resubmission-biologics-201330645.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Aug. 03, 2017-- Portola Pharmaceuticals Inc. ® today announced that on August 3, 2017 it resubmitted its Biologics License Application to the Center for Biologics Evaluation ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Announce Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 9",2017-08-02 12:00:00 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-announce-second-quarter-120000648.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Aug. 02, 2017-- Portola Pharmaceuticals, Inc. ® announced today that it will host a webcast and conference call to discuss the Company’ s financial results for the quarter ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Kornitzer Capital Management Inc  Buys Portola Pharmaceuticals Inc, WABCO Holdings Inc, ...",2017-07-28 13:56:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fPCn2mzu1PE/kornitzer-capital-management-inc-buys-portola-pharmaceuticals-inc-wabco-holdings-inc-cm823112,Kornitzer Capital Management Inc New Purchases PTLA WBC BBRY MSI MAT GWRE SMTC JBT THS TWNK Added Positions ADI AMZN SLB NVRO IPHI APA SHPG AKAM ZEN XRAY Reduced Positions AKRX HSY CSGP WSM MSFT CGNX CLX INXN TXN AAPL
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),2017-07-27 20:09:16 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-reports-inducement-grants-200916554.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., July 27, 2017-- Portola Pharmaceuticals, Inc. ® announced today that on July 25, 2017, the Compensation Committee of the Board of Directors approved, effective as of July 31, ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Commit To Buy Portola Pharmaceuticals At $50, Earn 14.6% Using Options",2017-07-26 16:58:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S5SQ4WMnASg/commit-to-buy-portola-pharmaceuticals-at-50-earn-146-using-options-cm821803,Investors considering a purchase of Portola Pharmaceuticals Inc Symbol PTLA stock but cautious about paying the going market price of 65 67 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular
PTLA,PTLA:UW,BBG004FJG6B0,Cramer: Don't Risk It All on a Small Biotech Unless You're Willing to Lose It All,2017-07-20 23:01:00 +0000,http://finance.yahoo.com/r/6ca7e8cb-78a4-3721-849c-f3cd4aa1dd5d/cramer-dont-risk-it-all-small-biotech-unless-youre-willing-lose-it-all?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Without at least one approved drug, I am tempted to say you should just take a pass."
PTLA,PTLA:UW,BBG004FJG6B0,Cramer Remix: Snap is the No. 1 reason to own Facebook,2017-07-19 23:25:00 +0000,https://finance.yahoo.com/video/cramer-remix-snap-no-1-232500551.html?.tsrc=rss,Jim Cramer broke down his strategy to why Snap fell out of his favor.
PTLA,PTLA:UW,BBG004FJG6B0,Cramer Remix: Snap is the No. 1 reason to own Facebook,2017-07-19 23:00:14 +0000,http://finance.yahoo.com/r/32bac854-3cb7-3885-bce5-ba9be327b56c/104596185?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104596185&yptr=yahoo&.tsrc=rss,Jim Cramer broke down his strategy to why Snap fell out of his favor.
PTLA,PTLA:UW,BBG004FJG6B0,Cramer Remix: Snap is the No. 1 reason to own Facebook,2017-07-19 23:00:14 +0000,https://finance.yahoo.com/news/cramer-remix-snap-no-1-230014737.html?.tsrc=rss,Jim Cramer broke down his strategy to why Snap fell out of his favor.
PTLA,PTLA:UW,BBG004FJG6B0,Is It Time to Sell Portola?,2017-07-14 12:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tea6P9yCpN8/is-it-time-to-sell-portola-cm815992,Portola Pharmaceuticals NASDAQ PTLA stock recently jumped 45 on the news that it won its first FDA approval In this segment of Industry Focus Healthcare Motley Fool analyst Kristine Harjes and contributor Todd Campbell explain why investors might want to stick
PTLA,PTLA:UW,BBG004FJG6B0,Is It Time to Sell Portola?,2017-07-14 11:19:00 +0000,http://finance.yahoo.com/r/14ad57ce-8a58-350d-9c9f-ac2dd9803941/is-it-time-to-sell-portola.aspx?yptr=yahoo&.tsrc=rss,"After the biopharma&apos;s 45% pop, many investors are wondering if maybe now is the time to cash out of this volatile stock."
PTLA,PTLA:UW,BBG004FJG6B0,Portola's Hitting All-Time Highs: Here's Why the Stock Should Go Higher,2017-07-13 12:51:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_zcN1Ig5IFE/portolas-hitting-all-time-highs-heres-why-the-stock-should-go-higher-cm815381,Portola Pharmaceuticals NASDAQ PTLA 160 won FDA approval of their first commercial drug Bevyxxa in June and that sent shares skyrocketing Yet the market opportunity for Bevyxxa could total in the billions of dollars annually and the potential approval of a second
PTLA,PTLA:UW,BBG004FJG6B0,Portola&apos;s Hitting All-Time Highs: Here&apos;s Why the Stock Should Go Higher,2017-07-13 11:30:00 +0000,http://finance.yahoo.com/r/14fb7ad7-eb6d-3512-8f9d-eeaac96be616/portolas-hitting-all-time-highs-heres-why-the-stoc.aspx?yptr=yahoo&.tsrc=rss,"Portola Pharmaceuticals&apos; stock price values the company at $3.5 billion, and I think that&apos;s too low."
PTLA,PTLA:UW,BBG004FJG6B0,How Portola Is Looking to Change the Anticoagulant Game,2017-07-11 12:46:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FhNRVkn2Jsw/how-portola-is-looking-to-change-the-anticoagulant-game-cm814211,Portola Pharmaceuticals NASDAQ PTLA received its first FDA approval recently for a drug called Bevyxxa but that s not the only reason why investors are taking notice of the company In this segment from Industry Focus Healthcare Motley Fool analyst
PTLA,PTLA:UW,BBG004FJG6B0,How Portola Is Looking to Change the Anticoagulant Game,2017-07-11 11:18:00 +0000,http://finance.yahoo.com/r/45998dcf-5965-3d57-89bb-6265ea96031a/how-portola-is-looking-to-change-the-anticoagulant.aspx?yptr=yahoo&.tsrc=rss,The biopharma is getting help from some of the biggest players in the drugmaking industry to develop its newest drug.
PTLA,PTLA:UW,BBG004FJG6B0,What Was Behind Portola Pharmaceuticals' 45% Pop?,2017-07-06 20:45:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v5RjERtzD1I/what-was-behind-portola-pharmaceuticals-45-pop-cm812665,On June 23 Portola Pharmaceuticals NASDAQ PTLA jumped 45 on the news that its first commercial drug Bevyxxa secured FDA approval Healthcare and biotech investors take note Bevyxxa has a massive potential patient pool and its drug class is already raking in billions of
PTLA,PTLA:UW,BBG004FJG6B0,What Was Behind Portola Pharmaceuticals&apos; 45% Pop?,2017-07-06 18:35:00 +0000,http://finance.yahoo.com/r/c43db663-6d15-37c0-a4b5-fb9b82a377c7/what-was-behind-portola-pharmaceuticals-45-pop.aspx?yptr=yahoo&.tsrc=rss,The biopharma&apos;s first FDA-approved drug has huge potential to be a blockbuster.
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and Andexanet Alfa at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Scientific and Standardization Committee Meeting,2017-07-06 12:00:00 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-announces-upcoming-data-120000526.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., July 06, 2017-- Portola Pharmaceuticals Inc. ® today announced that data on betrixaban and andexanet alfa, as well as presentations on disease awareness and risk, would be ..."
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Skyrocketed 54% in June,2017-07-06 02:43:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jP9Q3I-W0-w/why-portola-pharmaceuticals-skyrocketed-54-in-june-cm812173,What happened Investors weren t banking on FDA approval of Portola Pharmaceuticals NASDAQ PTLA first commercial drug Bevyxxa so when regulators issued a green light last month it caused the company s shares to surge 54 higher 160 according to S amp P Global
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Skyrocketed 54% in June,2017-07-06 01:01:00 +0000,http://finance.yahoo.com/r/7115fb14-5fc1-3849-ba90-436f3dfcf4e3/why-portola-pharmaceuticals-skyrocketed-54-in-june.aspx?yptr=yahoo&.tsrc=rss,A less-than-expected FDA approval sent shares soaring higher last month.
PTLA,PTLA:UW,BBG004FJG6B0,3 Mid-Cap Biotech Stocks That May Be Red-Hot Takeover Candidates,2017-07-05 17:47:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z_CwCgRHMrQ/3-mid-cap-biotech-stocks-that-may-be-red-hot-takeover-candidates-cm811949,With few exceptions the drug industry is divided into two factions the haves and the have nots The haves are drug companies that have approved products and are generally profitable Unfortunately the haves are also usually slow growing especially those that would fall within
PTLA,PTLA:UW,BBG004FJG6B0,3 Mid-Cap Biotech Stocks That May Be Red-Hot Takeover Candidates,2017-07-05 15:44:00 +0000,http://finance.yahoo.com/r/6629dbc8-b315-367e-a80e-d74673c30b34/3-mid-cap-biotech-stocks-that-may-be-red-hot-takeo.aspx?yptr=yahoo&.tsrc=rss,"If Big Pharma is looking to boost its growth rate, these three biotech stocks would likely do just that."
PTLA,PTLA:UW,BBG004FJG6B0,"The CBO Trips Up Trumpcare, Plus a Biotech &quot;Spiffy-Pop",2017-07-02 12:42:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LOwJyeXUuP0/the-cbo-trips-up-trumpcare-plus-a-biotech-spiffy-pop-cm810925,If the 160 Better Care Reconciliation Act of 2017 BCRA 160 eventually becomes law and replaces Obamacare the Congressional Budget Office CBO estimates 22 million Americans will end up uninsured 160 by 2026 Following the CBO s report Senate Majority Leader Mitch
PTLA,PTLA:UW,BBG004FJG6B0,"The CBO Trips Up Trumpcare, Plus a Biotech &quot;Spiffy-Pop",2017-07-02 11:21:00 +0000,http://finance.yahoo.com/r/8cd71da6-345b-381c-9807-e36f98671d07/the-cbo-trips-up-trumpcare-plus-a-biotech-spiffy-p.aspx?yptr=yahoo&.tsrc=rss,"The Congressional Budget Office announces a discouraging outlook for Trumpcare. Meanwhile, Portola Pharmaceuticals&apos; stock price increases more in one day than it cost last November."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Inc (PTLA) CEO William Lis Sold $14.9 million of Shares,2017-06-30 22:41:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CRw7s7rvpA0/portola-pharmaceuticals-inc-ptla-ceo-william-lis-sold-149-million-of-shares-cm810798,CEO of Portola Pharmaceuticals Inc PTLA William Lis sold 269 299 shares of PTLA on 06 28 2017 at an average price of 55 43 a share The total sale was 14 9 million CEO of Portola Pharmaceuticals Inc PTLA William Lis sold 269 299 shares of PTLA on 06 28 2017 at an average price
PTLA,PTLA:UW,BBG004FJG6B0,Is It Too Late to Buy Portola Pharmaceuticals Stock?,2017-06-29 22:03:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Ibp8W6ORvU/is-it-too-late-to-buy-portola-pharmaceuticals-stock-cm810244,Portola Pharmaceuticals NASDAQ PTLA is enjoying the best year ever at least in terms of stock performance After losing more than half of its market cap last year the biotech s share price is up more than 140 so far in 2017 There has been nothing but good news for Portola
PTLA,PTLA:UW,BBG004FJG6B0,Is It Too Late to Buy Portola Pharmaceuticals Stock?,2017-06-29 20:43:00 +0000,http://finance.yahoo.com/r/968f4ff2-5ac3-33bc-8390-7b4b7b3a88e3/is-it-too-late-to-buy-portola-pharmaceuticals-stoc.aspx?yptr=yahoo&.tsrc=rss,Portola Pharmaceuticals stock is soaring. Can it go even higher?
PTLA,PTLA:UW,BBG004FJG6B0,Biotech Stocks Facing FDA Decision In July,2017-06-29 00:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pgpziX5aPwc/biotech-stocks-facing-fda-decision-in-july-20170629-00014,Biotech Stocks Facing FDA Decision In July
PTLA,PTLA:UW,BBG004FJG6B0,These 3 Small Biotechs Have a Healthy Shot,2017-06-28 19:30:00 +0000,http://finance.yahoo.com/r/11e845da-e3c3-32fc-955e-2a1f2c9228c2/these-3-small-biotechs-have-healthy-shot?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Several firms hiked price targets on Portola into the $70s this week.
PTLA,PTLA:UW,BBG004FJG6B0,These 3 Biotech Stocks Have Doubled This Year; Can They Keep Climbing?,2017-06-27 21:51:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pwTATs_MWO4/these-3-biotech-stocks-have-doubled-this-year-can-they-keep-climbing-cm809078,It s been a spectacular year for Cara Therapeutics Inc NASDAQ CARA Omeros Corporation NASDAQ OMER and Portola Pharmaceuticals Inc NASDAQ PTLA shareholders Now that all three of these drugmaker stocks have more than doubled in price this year investors
PTLA,PTLA:UW,BBG004FJG6B0,These 3 Biotech Stocks Have Doubled This Year; Can They Keep Climbing?,2017-06-27 20:27:00 +0000,http://finance.yahoo.com/r/7f3508c1-003c-3f5a-945e-67042a382081/these-3-biotech-stocks-have-doubled-this-year-can.aspx?yptr=yahoo&.tsrc=rss,Find out if these biotech stock rockets have any more fuel in the tank.
PTLA,PTLA:UW,BBG004FJG6B0,Corporate News Blog - US FDA Approves Portola's Anticoagulant for High-risk Patients with Thromboembolic Complications,2017-06-27 12:15:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-us-fda-121500682.html?.tsrc=rss,"Research Desk Line-up: OncoSec Medical Post Earnings Coverage LONDON, UK / ACCESSWIRE / June 27, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Portola ..."
PTLA,PTLA:UW,BBG004FJG6B0,Oppenheimer Boosts Price Target for Portola Pharmaceuticals Inc (PTLA) Following FDA Approval,2017-06-26 16:54:52 +0000,https://finance.yahoo.com/news/oppenheimer-boosts-price-target-portola-165452655.html?.tsrc=rss,"Oppenheimer analyst Jay Olson weighs in on shares of Portola Pharmaceuticals Inc (NASDAQ:PTLA) after the drug maker received FDA approval for betrixaban to prevent venous thromboembolism (VTE) in adult patients hospitalized for an acute medical illness who are at risk. The analyst reiterates an Outperform rating on the stock, while boosting the price target to $66.00 (from $46.00), which represents a potential upside of 19% from where PTLA is currently trading."
PTLA,PTLA:UW,BBG004FJG6B0,"Company News for June 26, 2017",2017-06-26 16:49:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H-PtvtbpN2c/company-news-for-june-26-2017-cm808138,160 160 160 Shares of BlackBerry Ltd BBRY declined 12 2 after reporting fiscal first quarter revenues of 244 million missing the Zacks consensus estimate of 264 million 160 160 160 Synchronoss Technologies Inc s SNCR shares skyrocketed 33 3 following news that
PTLA,PTLA:UW,BBG004FJG6B0,PTLA Crosses Above Average Analyst Target,2017-06-26 14:52:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RFepscSnVUU/ptla-crosses-above-average-analyst-target-cm808017,In recent trading shares of Portola Pharmaceuticals Inc Symbol PTLA have crossed above the average analyst 12 month target price of 47 00 changing hands for 56 06 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on
PTLA,PTLA:UW,BBG004FJG6B0,"Company News for June 26, 2017",2017-06-26 14:16:02 +0000,https://finance.yahoo.com/news/company-news-june-26-2017-141602739.html?.tsrc=rss,"Companies in the News are: BBRY,SNCR,BBBY,PTLA"
PTLA,PTLA:UW,BBG004FJG6B0,Edited Transcript of PTLA earnings conference call or presentation 8-May-17 8:30pm GMT,2017-06-26 14:05:11 +0000,https://finance.yahoo.com/news/edited-transcript-ptla-earnings-conference-015055503.html?.tsrc=rss,Q1 2017 Portola Pharmaceuticals Inc Earnings Call
PTLA,PTLA:UW,BBG004FJG6B0,Biotech Stocks Showing Signs of Resurgence,2017-06-26 12:30:00 +0000,https://finance.yahoo.com/news/biotech-stocks-showing-signs-resurgence-123000078.html?.tsrc=rss,The Nasdaq Biotechnology Index (NBI) surged last week as Research and Development for the advancement of rare cancer therapies and anti-cancer drug candidates heat up with new partnerships with Mayo Clinic as part of a process for creating and delivering treatments to reach the patients who need them the most.  The Oncology segment is one of the largest markets in medicine that's expected to grow to $165 billion by 2021.
PTLA,PTLA:UW,BBG004FJG6B0,Today's Research Reports on Stocks to Watch: Portola and AVEO,2017-06-26 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000483.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 26, 2017 / Portola and AVEO Pharmaceuticals were huge winners on Friday, both hitting new highs on drug approval news. While Portola got a nod of approval from the FDA ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals' FDA Nod Could Spark M&A Interest,2017-06-24 13:51:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dgzi__jOhkk/portola-pharmaceuticals-fda-nod-could-spark-ma-interest-cm807751,Portola Pharmaceuticals NASDAQ PTLA 160 investors who stuck with it after stumbles caused share prices to crash last year are feeling a bit better about their position today On Friday the Food and Drug Administration approved the company s first drug 160 Bevyxxa and
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals&apos; FDA Nod Could Spark M&A Interest,2017-06-24 12:03:00 +0000,http://finance.yahoo.com/r/f4d78d7a-5352-35d8-800c-2acfc9b9fea7/portola-pharmaceuticals-fda-nod-could-spark-ma-int.aspx?yptr=yahoo&.tsrc=rss,"The FDA has approved its first commercial medicine, and because it could reshape a big indication, the company may have just gotten a lot more interesting to suitors."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Inc.'s Green Light Sends Its Stock Soaring as Much as 51%,2017-06-23 21:50:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DwO9xmf8Noc/portola-pharmaceuticals-incs-green-light-sends-its-stock-soaring-as-much-as-51-cm807660,What happened Shares of Portola Pharmaceuticals NASDAQ PTLA a biotech company focused on the development of drugs designed to treat thrombosis bleeding disorders and inflammation skyrocketed by as much as 51 following a trading halt after the company announced that
PTLA,PTLA:UW,BBG004FJG6B0,"Why Synchronoss Technologies, AK Steel Holding, and Portola Pharmaceuticals Jumped Today",2017-06-23 21:49:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RM1ArRN3Lew/why-synchronoss-technologies-ak-steel-holding-and-portola-pharmaceuticals-jumped-today-cm807647,Friday was another day of marking time for the stock market as major benchmarks all finished the last session of the week close to the unchanged mark Volatility fell to nearly unprecedented levels as the ongoing tug of war continued between bullish investors who are optimistic about
PTLA,PTLA:UW,BBG004FJG6B0,"Health Care Sector Update for 06/23/2017: PLTA,AVEO,OCUL",2017-06-23 20:29:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Cakr2JYvCU/health-care-sector-update-for-06232017-pltaaveoocul-cm807636,Top Health Care StocksTop Health Care Stocks JNJ 0 24 JNJ 0 24 PFE 0 32 PFE 0 32 ABT 0 43 ABT 0 43 MRK 0 19 MRK 0 19 AMGN 0 61 AMGN 0 61 Health care stocks turned lower this afternoon with the NYSE Health Care Index falling about 0 3 giving back a narrow advance earlier today
PTLA,PTLA:UW,BBG004FJG6B0,"Why Synchronoss Technologies, AK Steel Holding, and Portola Pharmaceuticals Jumped Today",2017-06-23 20:29:00 +0000,http://finance.yahoo.com/r/7ad27ba8-6310-3eba-9dc7-044dc5c3f1f6/why-synchronoss-technologies-ak-steel-holding-and.aspx?yptr=yahoo&.tsrc=rss,"Even though the market didn&apos;t move much, these stocks climbed. Find out why."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Inc.&apos;s Green Light Sends Its Stock Soaring as Much as 51%,2017-06-23 19:58:00 +0000,http://finance.yahoo.com/r/8c46d216-4bfb-350e-91d6-ca4cced85bbc/portola-pharmaceuticals-incs-green-light-sends-its.aspx?yptr=yahoo&.tsrc=rss,"Say hello to Portola&apos;s newly FDA-approved therapy, Bevyxxa."
PTLA,PTLA:UW,BBG004FJG6B0,Portola shares soar after FDA approves clot preventing drug,2017-06-23 19:18:02 +0000,https://finance.yahoo.com/news/u-fda-approves-portola-blood-162709325.html?.tsrc=rss,"The U.S. Food and Drug  Administration on Friday approved a new oral blood-thinner made  by Portola Pharmaceuticals Inc to prevent deep vein  thrombosis and pulmonary embolisms in acutely ill patients who  are not undergoing surgery.  The news sent Portola's shares up as much as 51 percent to  $57.90.  The drug, BevyxXa, known also as betrixaban, is the first  oral treatment and first extended duration treatment for this  patient population, the company said."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharma stock skyrockets after FDA approves anticoagulant for high-risk patients,2017-06-23 18:00:23 +0000,http://finance.yahoo.com/r/c20330d3-826b-3699-91aa-daa06966fa02/Story.aspx?guid=8CF69CAB-787D-4CF2-855D-B1194D556BAE&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Portola Pharmaceuticals Inc. shares skyrocketed 46% in extremely heavy Friday afternoon trade after the Food and Drug Administration approved its anticoagulant drug intended for high-risk patients. The ...
PTLA,PTLA:UW,BBG004FJG6B0,FDA approves Portola's blood-thinning drug,2017-06-23 17:44:00 +0000,https://finance.yahoo.com/video/fda-approves-portolas-blood-thinning-174400833.html?.tsrc=rss,CNBC's Morgan Brennan reports on the FDA approving Portola's blood-thinning drug and the company's stock reaction.
PTLA,PTLA:UW,BBG004FJG6B0,U.S. FDA Approves Bevyxxa® (betrixaban) First and Only Anticoagulant for Hospital and Extended Duration Prevention of Venous Thromboembolism (VTE) in Acutely Ill Medical Patients,2017-06-23 17:04:59 +0000,https://finance.yahoo.com/news/u-fda-approves-bevyxxa-betrixaban-170459584.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., June 23, 2017-- Portola Pharmaceuticals Inc. ® today announced the U.S. Food and Drug Administration has approved Bevyxxa, the first and only anticoagulant for hospital and ..."
PTLA,PTLA:UW,BBG004FJG6B0,Citi Says Expect FDA PDUFA Decision For Portola Pharma Early,2017-06-23 14:52:45 +0000,https://finance.yahoo.com/news/citi-says-expect-fda-pdufa-145245729.html?.tsrc=rss,Portola Pharmaceuticals Inc (NASDAQ: PTLA ) investors should be marking Friday on their calendars. Citi analyst Yigal Nochomovitz expects the Food and Drug Administration to release its decision on betrixaban ...
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PTLA-US : June 21, 2017",2017-06-21 12:07:40 +0000,http://finance.yahoo.com/r/5996ea58-9079-3338-8202-fc79979533d8/portola-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-ptla-us-june-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Portola Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,Biotech Industry Showing Signs of a Revival in 2017: Today's Research on Lipocine and Portola Pharmaceuticals,2017-06-21 12:00:00 +0000,https://finance.yahoo.com/news/biotech-industry-showing-signs-revival-120000097.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 21, 2017 / The Biotech Industry has continued to outperform the broader markets in 2017. Biotech companies appear to be benefitting from a speedier FDA approval process ..."
PTLA,PTLA:UW,BBG004FJG6B0,Implied Volatility Surging for Portola Pharmaceuticals (PTLA) Stock Options,2017-06-20 14:24:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D9TyyTI9JPo/implied-volatility-surging-for-portola-pharmaceuticals-ptla-stock-options-cm805525,Investors in Portola Pharmaceuticals Inc PTLA need to pay close attention to the stock based on moves in the options market lately That is because the July 21 st 2017 25 00 Put had some of the highest implied volatility of all equity options today What is Implied
PTLA,PTLA:UW,BBG004FJG6B0,Implied Volatility Surging for Portola Pharmaceuticals (PTLA) Stock Options,2017-06-20 12:43:12 +0000,https://finance.yahoo.com/news/implied-volatility-surging-portola-pharmaceuticals-124312909.html?.tsrc=rss,Investors need to pay close attention to Portola Pharmaceuticals (PTLA) stock based on the movements in the options market lately.
PTLA,PTLA:UW,BBG004FJG6B0,Here Comes a Big Breakout For Alibaba,2017-06-20 10:30:00 +0000,http://finance.yahoo.com/r/c448d401-ab06-38ba-b6bb-0637c0a67d81/here-comes-a-big-breakout-for-alibaba.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,What the charts say.
PTLA,PTLA:UW,BBG004FJG6B0,"Notable Monday Option Activity: PTLA, FLT, NUS",2017-06-19 21:19:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ArRqaqv8tkI/notable-monday-option-activity-ptla-flt-nus-cm805339,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Portola Pharmaceuticals Inc Symbol PTLA where a total of 16 153 contracts have traded so far representing approximately 1 6 million underlying shares That amounts to about 255
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Presents Interim Phase 2a Safety and Efficacy Data for Cerdulatinib at the International Congress of Malignant Lymphoma,2017-06-15 12:30:00 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-presents-interim-phase-123000957.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., June 15, 2017-- Portola Pharmaceuticals Inc. ® today announced the presentation of interim data from a Phase 2 a study evaluating cerdulatinib in patients with relapsed/refractory ..."
PTLA,PTLA:UW,BBG004FJG6B0,"ETFs with exposure to Portola Pharmaceuticals, Inc. : June 9, 2017",2017-06-09 17:53:02 +0000,http://finance.yahoo.com/r/997111b6-9368-3151-94aa-16999d0f2529/etfs-with-exposure-to-portola-pharmaceuticals-inc-june-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Portola Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PTLA-US. Comparing the performance and risk of Portola Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,"Monday 6/5 Insider Buying Report: AVT, PTLA",2017-06-05 16:01:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mKAr41Ylwxc/monday-65-insider-buying-report-avt-ptla-cm798682,Bargain hunters are wise to pay careful attention to insider buying because although there are many various reasons for an insider to sell a stock presumably the only reason they would use their hard earned dollars to make a purchase is that they expect to make money Today we look at
PTLA,PTLA:UW,BBG004FJG6B0,Key FDA Events to Watch Out for in Jun 2017,2017-06-05 11:47:11 +0000,https://finance.yahoo.com/news/key-fda-events-watch-jun-114711878.html?.tsrc=rss,Companies like Portola (PTLA) are awaiting key FDA decisions this month which could send their stocks soaring in case of a positive response.
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Could Be a Great June Trade,2017-06-02 17:27:09 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-could-great-june-172709450.html?.tsrc=rss,A look at the upcoming FDA decision for 1 of the company's 2 lead assets
PTLA,PTLA:UW,BBG004FJG6B0,Two Red Hot Biotechs With Big Near-term Catalysts Ahead,2017-05-28 20:30:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AYyOxtPjIpM/two-red-hot-biotechs-with-big-near-term-catalysts-ahead-cm795783,June is shaping up to be a pivotal month for shareholders of Neos Therapeutics NASDAQ NEOS and Portola Pharmaceuticals NASDAQ PTLA Neos is gearing up for the potential launch of their second ever product while Portola is awaiting the early anticipated ruling from the FDA
PTLA,PTLA:UW,BBG004FJG6B0,Two Red Hot Biotechs With Big Near-term Catalysts Ahead,2017-05-28 19:20:00 +0000,http://finance.yahoo.com/r/99f28944-6610-3d57-8867-5521e6cade0c/two-red-hot-biotechs-with-big-near-term-catalysts.aspx?yptr=yahoo&.tsrc=rss,June will be a pivotal month for shareholders of Portola Pharmaceuticals and Neos Therapeutics
PTLA,PTLA:UW,BBG004FJG6B0,Biotech Stocks Facing FDA Decision In June,2017-05-25 05:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a9bvKdScdD8/biotech-stocks-facing-fda-decision-in-june-20170525-00145,Biotech Stocks Facing FDA Decision In June
PTLA,PTLA:UW,BBG004FJG6B0,"ETFs with exposure to Portola Pharmaceuticals, Inc. : May 22, 2017",2017-05-22 18:02:50 +0000,http://finance.yahoo.com/r/c93ef82e-b691-3443-8195-568b51122c14/etfs-with-exposure-to-portola-pharmaceuticals-inc-may-22-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Portola Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PTLA-US. Comparing the performance and risk of Portola Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PTLA-US : May 22, 2017",2017-05-22 12:38:31 +0000,http://finance.yahoo.com/r/23ddb2d6-0377-3c96-97f3-ad4979d579e8/portola-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-ptla-us-may-22-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Portola Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,"These 3 Biotech Stocks Have Ballooned in 2017, but Will They Pop?",2017-05-22 12:07:00 +0000,http://finance.yahoo.com/r/0fb98c35-8456-34f5-979b-0ee31950e5a9/these-3-biotech-stocks-have-ballooned-in-2017-but.aspx?yptr=yahoo&.tsrc=rss,"It&apos;s been a pretty good year for biotech, but these three stocks are outperforming their industry peers. Can they keep it up?"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Phase 2a Safety and Efficacy Cerdulatinib Data to be Presented at the European Hematology Association (EHA),2017-05-18 12:00:00 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-announces-phase-2a-120000096.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., May 18, 2017-- Portola Pharmaceuticals Inc. ® today announced that preclinical and clinical data on cerdulatinib in relapsed/refractory b-cell malignancies will be presented ..."
PTLA,PTLA:UW,BBG004FJG6B0,"ETFs with exposure to Portola Pharmaceuticals, Inc. : May 11, 2017",2017-05-11 21:23:44 +0000,http://finance.yahoo.com/r/b50beb29-d0ad-3d09-a73d-334cb3eb6f89/etfs-with-exposure-to-portola-pharmaceuticals-inc-may-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Portola Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PTLA-US. Comparing the performance and risk of Portola Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,3 Top Biotech Stocks For May,2017-05-11 15:05:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0UV5v70_W1I/3-top-biotech-stocks-for-may-cm787789,After a dreadful 2016 biotech stocks have rebounded nicely this year for a variety of reasons Most importantly though the specter of government mandated price caps on specialty medicines appears to have faded into the background at least for the time being So to take
PTLA,PTLA:UW,BBG004FJG6B0,3 Top Biotech Stocks For May,2017-05-11 13:17:00 +0000,http://finance.yahoo.com/r/9396a51d-aacf-301d-9ab6-e25289bb2423/3-top-biotech-stocks-for-may.aspx?yptr=yahoo&.tsrc=rss,These three biotechs could be stellar buys this month.
PTLA,PTLA:UW,BBG004FJG6B0,"Fernwood Investment Management, LLC Buys Global Blood Therapeutics Inc, Ubiquiti Networks Inc, ...",2017-05-10 16:00:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/egQV5ke1aKE/fernwood-investment-management-llc-buys-global-blood-therapeutics-inc-ubiquiti-networks-inc-cm787284,Fernwood Investment Management LLC New Purchases UBNT TPL CLB OLED ARRS EMB THRM 4ETA MNST TRGP Added Positions GBT JNK SAGE CTRP MO LUK FB JNJ YUMC XOM Reduced Positions AAPL ARCC PTLA SAFT BKLN ALGN CAT V IDU BIIB
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. :PTLA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017",2017-05-10 14:14:09 +0000,http://finance.yahoo.com/r/e4d4471e-2a07-3535-89d1-b3fad5a7cfa3/portola-pharmaceuticals-inc-ptla-us-earnings-analysis-q1-2017-by-the-numbers-may-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Portola Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Portola Pharmaceuticals, Inc. – Johnson & Johnson, Biogen Inc., Bristol-Myers Squibb Company and Pfizer Inc. (JNJ-US, BIIB-US, BMY-US and PFE-US) that have also reported for this period. Highlights ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Shot 12.8% Higher Today,2017-05-09 23:02:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MI_yuzmYRVU/why-portola-pharmaceuticals-shot-128-higher-today-cm786874,What happened After updating investors on its progress in the first quarter shares in Portola Pharmaceuticals NASDAQ PTLA rallied 12 8 higher Tuesday So what Portola Pharmaceuticals reported first quarter financials after the closing bell on Monday and while the company
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Shot 12.8% Higher Today,2017-05-09 21:50:00 +0000,http://finance.yahoo.com/r/563793c8-01a5-3823-a8cc-72561f4614d2/why-portola-pharmaceuticals-shot-127-higher-today.aspx?yptr=yahoo&.tsrc=rss,A solid first-quarter financials report and an advance toward commercialization of its first product sparked optimism.
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PTLA) : May 9, 2017",2017-05-09 21:39:37 +0000,http://finance.yahoo.com/r/06ae1844-8712-353c-9b77-5ff6ab4cfe0b/portola-pharmaceuticals-inc-value-analysis-nasdaqptla-may-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Portola Pharmaceuticals, Inc. a score of 8. Our analysis is based on comparing Portola Pharmaceuticals, Inc. with the following peers – Johnson & Johnson, Biogen Inc., Sanofi Sponsored ADR, Bristol-Myers Squibb Company and Pfizer Inc. (JNJ-US, BIIB-US, SNY-US, BMY-US and PFE-US). Investment Outlook Portola Pharmaceuticals, Inc. has ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,"Gainers & Losers Of May 9: VRX, ENDP, PTLA, SCYX, NXTM...",2017-05-09 20:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/heAx42q9Jds/gainers--losers-of-may-9-vrx-endp-ptla-scyx-nxtm-20170509-02070,"Gainers & Losers Of May 9: VRX, ENDP, PTLA, SCYX, NXTM..."
PTLA,PTLA:UW,BBG004FJG6B0,Edited Transcript of PTLA earnings conference call or presentation 8-May-17 8:30pm GMT,2017-05-09 13:00:52 +0000,http://finance.yahoo.com/news/edited-transcript-ptla-earnings-conference-015055503.html?.tsrc=rss,Q1 2017 Portola Pharmaceuticals Inc Earnings Call
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Cerdulatinib Data to be Presented at the International Conference on Malignant Lymphoma (ICML),2017-05-09 12:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-announces-cerdulatinib-data-120000875.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., May 09, 2017-- Portola Pharmaceuticals Inc. ® today announced that clinical results from the Phase 2 study of cerdulatinib in patients with relapsed/refractory b-cell malignancies ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals posts 1Q loss,2017-05-08 22:20:38 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-posts-1q-loss-222038798.html?.tsrc=rss,"On a per-share basis, the South San Francisco, California-based company said it had a loss of 74 cents. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update,2017-05-08 20:36:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-reports-first-quarter-203600936.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., May 08, 2017-- Portola Pharmaceuticals, Inc. today reported financial results and provided a corporate update for the quarter ended March 31, 2017.. “During the first quarter ..."
PTLA,PTLA:UW,BBG004FJG6B0,What I'm Learning From My Best And Worst Stock Picks,2017-05-08 19:03:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c9piX4ptuis/what-im-learning-from-my-best-and-worst-stock-picks-cm786041,Long term investors are going to have winners and losers in their portfolio But if they take the time to analyze their mistakes they can learn how to better avoid costly missteps in the future In this week s episode of Industry Focus Healthcare
PTLA,PTLA:UW,BBG004FJG6B0,"Investor Network: Portola Pharmaceuticals, Inc. to Host Earnings Call",2017-05-08 15:00:00 +0000,http://finance.yahoo.com/news/investor-network-portola-pharmaceuticals-inc-150000004.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 8, 2017 / Portola Pharmaceuticals, Inc. (NASDAQ: PTLA ) will be discussing their earnings results in their Q1 Earnings Call to be held May 8, 2017 at 4:30 PM Eastern Time. ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PTLA-US : May 8, 2017",2017-05-08 13:11:25 +0000,http://finance.yahoo.com/r/55b2cec2-15c2-3af3-85d8-1125e8184be3/portola-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-ptla-us-may-8-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Portola Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Announce First Quarter 2017 Financial Results and Host Conference Call on Monday, May 8",2017-05-01 12:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-announce-first-quarter-120000675.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., May 01, 2017-- Portola Pharmaceuticals, Inc. ® announced today that it will host a webcast and conference call to discuss the Company's financial results for the quarter ended ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Commit To Buy Portola Pharmaceuticals At $30, Earn 33.9% Annualized Using Options",2017-04-25 17:09:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ij0wzg2GI_c/commit-to-buy-portola-pharmaceuticals-at-30-earn-339-annualized-using-options-cm778858,Investors considering a purchase of Portola Pharmaceuticals Inc Symbol PTLA stock but cautious about paying the going market price of 39 92 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular
PTLA,PTLA:UW,BBG004FJG6B0,Why Shares of Portola Pharmaceuticals Are Up Over 60% in 2017,2017-04-17 14:58:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-AcK9AKShWE/why-shares-of-portola-pharmaceuticals-are-up-over-60-in-2017-cm774581,2017 has been a great year for investors of Portola Pharmaceuticals NASDAQ PTLA with shares up almost 70 year to date The reason for the run A combination one two punch of an FDA resubmission combined with a priority review has led to a substantial rise in the stock So can
PTLA,PTLA:UW,BBG004FJG6B0,Why Shares of Portola Pharmaceuticals Are Up Over 60% in 2017,2017-04-17 13:01:00 +0000,http://finance.yahoo.com/r/befa848e-447c-3cdc-b38f-f161ed0c2316/why-shares-of-portola-pharmaceuticals-are-up-over.aspx?yptr=yahoo&.tsrc=rss,A combination one-two punch has left investors cheering
PTLA,PTLA:UW,BBG004FJG6B0,Analysts Predict 11% Gains Ahead For The Holdings of IYH,2017-04-12 14:55:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x-yZxnZPXgo/analysts-predict-11-gains-ahead-for-the-holdings-of-iyh-cm773146,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
PTLA,PTLA:UW,BBG004FJG6B0,Losing Money on a Stock? Blame Your Brain,2017-04-10 15:57:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nmX3YfciLDk/losing-money-on-a-stock-blame-your-brain-cm772166,In this episode of Industry Focus Healthcare Motley Fool analyst Kristine Harjes is joined by contributor Todd Campbell to investigate the relationship between 160 psychology and investing and explain how you can 160 outsmart your 160 biases A
PTLA,PTLA:UW,BBG004FJG6B0,Losing Money on a Stock? Blame Your Brain,2017-04-10 14:04:00 +0000,http://finance.yahoo.com/r/873c8e9f-9185-3ce4-966f-d037105d568f/losing-money-on-a-stock-blame-your-brain.aspx?yptr=yahoo&.tsrc=rss,"We all have cognitive biases, but if we&apos;re not careful, they can lead to bad investments."
PTLA,PTLA:UW,BBG004FJG6B0,"Noteworthy Friday Option Activity: PTLA, CSV, SAGE",2017-04-07 20:53:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ekuGzhHpiss/noteworthy-friday-option-activity-ptla-csv-sage-cm771586,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Portola Pharmaceuticals Inc Symbol PTLA where a total volume of 6 308 contracts has been traded thus far today a contract volume which is representative of
PTLA,PTLA:UW,BBG004FJG6B0,"ETFs with exposure to Portola Pharmaceuticals, Inc. : April 5, 2017",2017-04-05 21:19:42 +0000,http://finance.yahoo.com/r/9274e0ec-ba80-3275-bc9b-15e5692dd844/etfs-with-exposure-to-portola-pharmaceuticals-inc-april-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Portola Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PTLA-US. Comparing the performance and risk of Portola Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,3 Hot Stocks to Buy in April,2017-04-04 15:03:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Uz7-4252eeE/3-hot-stocks-to-buy-in-april-cm769482,It s natural for investors to shy away from buying high flying stocks However sometimes a stock takes off because of thesis changing news When that happens it can sometimes make sense to buy even after a stock has gone on a big run Dexcom NASDAQ DXCM Shopify
PTLA,PTLA:UW,BBG004FJG6B0,3 Hot Stocks to Buy in April,2017-04-04 12:48:00 +0000,http://finance.yahoo.com/r/ffce4948-15b2-36b2-8535-85cfaa2d7f01/3-hot-stocks-to-buy-in-march.aspx?yptr=yahoo&.tsrc=rss,"Dexcom, Shopify, and Portola Pharmaceuticals have been on an absolute tear in 2017. Here&apos;s why shareholders should expect the trend to continue."
PTLA,PTLA:UW,BBG004FJG6B0,My 3 Top Biotech Stocks to Buy Now,2017-03-31 18:00:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aiQs59_Kf4k/my-3-top-biotech-stocks-to-buy-now-cm768421,Celgene Corp NASDAQ CELG Ionis Pharmaceuticals NASDAQ IONS and Portola Pharmaceuticals NASDAQ PTLA may be at different stages of drug development but all three have intriguing catalysts that could make them top stocks to buy No 1 Expanding its reach
PTLA,PTLA:UW,BBG004FJG6B0,My 3 Top Biotech Stocks to Buy Now,2017-03-31 16:00:00 +0000,https://www.fool.com/investing/2017/03/31/my-3-top-biotech-stocks-to-buy-now.aspx,My 3 Top Biotech Stocks to Buy Now
PTLA,PTLA:UW,BBG004FJG6B0,My 3 Top Biotech Stocks to Buy Now,2017-03-31 16:00:00 +0000,http://finance.yahoo.com/r/2fa664d8-5c0b-3e95-ad7b-972eb72c0db7/my-3-top-biotech-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,"Big news is on deck for Celgene, Ionis Pharmaceuticals, and Portola Pharmaceuticals that could send shares soaring higher."
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Stock Is Already Up an Eye-Popping 72% This Year,2017-03-16 15:08:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TTZWHVChsv0/why-portola-pharmaceuticals-stock-is-already-up-an-eye-popping-72-this-year-cm761619,Portola Pharmaceuticals NASDAQ PTLA could win approvals from the Food and Drug Administration for two important new drugs in the coming year Its drug betrixaban could become the first of a new class of drugs to be green lighted for reducing the chance of blood clots
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Stock Is Already Up an Eye-Popping 72% This Year,2017-03-16 13:22:00 +0000,http://finance.yahoo.com/r/d7c2ac01-5b97-30c4-b2db-c28afb07177d/why-portola-pharmaceuticals-stock-is-already-up-an.aspx?yptr=yahoo&.tsrc=rss,The potential to launch two blockbuster drugs in the next year is sparking optimism.
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Stock Is Already Up an Eye-Popping 72% This Year,2017-03-16 13:22:00 +0000,https://www.fool.com/investing/2017/03/16/why-portola-pharmaceuticals-stock-is-already-up-an.aspx,Why Portola Pharmaceuticals Stock Is Already Up an Eye-Popping 72% This Year
PTLA,PTLA:UW,BBG004FJG6B0,Top Stocks That Are Already Crushing the Market in 2017,2017-03-13 16:10:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/un7WrfHTuq0/top-stocks-that-are-already-crushing-the-market-in-2017-cm760028,If you re looking for new stocks to buy for your portfolio you might want to consider digging deeper into the story behind Exelixis NASDAQ EXEL Pacira Pharmaceuticals NASDAQ PCRX Kite Pharma NASDAQ KITE Exact Sciences NASDAQ EXAS
PTLA,PTLA:UW,BBG004FJG6B0,Top Stocks That Are Already Crushing the Market in 2017,2017-03-13 14:11:00 +0000,http://www.fool.com/investing/2017/03/13/top-stocks-that-are-already-crushing-the-market-in.aspx,Top Stocks That Are Already Crushing the Market in 2017
PTLA,PTLA:UW,BBG004FJG6B0,Top Stocks That Are Already Crushing the Market in 2017,2017-03-13 14:11:00 +0000,http://finance.yahoo.com/r/1bf14d85-525f-3e9b-af79-fa6fb62ba897/top-stocks-that-are-already-crushing-the-market-in.aspx?yptr=yahoo&.tsrc=rss,"Exelixis, Pacira Pharmaceuticals, Kite Pharma, Exact Sciences, and Portola Pharmaceuticals are up more than 50% in the first two months of 2017."
PTLA,PTLA:UW,BBG004FJG6B0,Blog Coverage Keryx Biopharma Announced FDA Review Approval for Auryxia(R) Tablets,2017-03-09 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-keryx-biopharma-announced-131500535.html?.tsrc=rss,"Upcoming AWS Coverage on Portola Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / March 9, 2017 / Active Wall St. blog coverage looks at the headline from Keryx Biopharmaceuticals, Inc. ..."
PTLA,PTLA:UW,BBG004FJG6B0,Blog Coverage Keryx Biopharma Announced FDA Review Approval for Auryxia(R) Tablets,2017-03-09 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-keryx-biopharma-announced-131500535.html,"[Accesswire] - Upcoming AWS Coverage on Portola Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / March 9, 2017 / Active Wall St. blog coverage looks at the headline from Keryx Biopharmaceuticals, Inc. ..."
PTLA,PTLA:UW,BBG004FJG6B0,4:10 pm Portola Pharma will present new data from the Phase 3 APEX Study of betrixaban at the upcoming American College of Cardiology's 66th Annual Scientific Session & Expo on March 17,2017-03-07 21:10:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#ptla,4:10 pm Portola Pharma will present new data from the Phase 3 APEX Study of betrixaban at the upcoming American College of Cardiology's 66th Annual Scientific Session & Expo on March 17
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Betrixaban and AndexXa™ (andexanet alfa) Presentations at ACC.17,2017-03-07 21:05:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-announces-betrixaban-andexxa-210500260.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., March 07, 2017-- Portola Pharmaceuticals Inc. ® today announced that new data from the pivotal Phase 3 APEX Study of the Company’ s investigational drug betrixaban will be ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Betrixaban and AndexXa™ (andexanet alfa) Presentations at ACC.17,2017-03-07 21:05:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-announces-betrixaban-andexxa-210500260.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., March 07, 2017-- Portola Pharmaceuticals Inc. ® today announced that new data from the pivotal Phase 3 APEX Study of the Company’ s investigational drug betrixaban will be ..."
PTLA,PTLA:UW,BBG004FJG6B0,PORTOLA PHARMACEUTICALS INC Financials,2017-03-07 18:04:16 +0000,http://finance.yahoo.com/q/is?s=ptla,PORTOLA PHARMACEUTICALS INC Financials
PTLA,PTLA:UW,BBG004FJG6B0,Is Portola Pharmaceuticals Balance Sheet Safe?,2017-03-07 16:14:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VVXHhkI5dqI/is-portola-pharmaceuticals-balance-sheet-safe-cm757227,Portola Pharmaceuticals NASDAQ PTLA 160 could have two commercial stage drugs on the market next year but turning them into top sellers will require a lot of money Is Portola Pharmaceuticals balance sheet flush enough with cash to get its drugs across the finish line What
PTLA,PTLA:UW,BBG004FJG6B0,Is Portola Pharmaceuticals Balance Sheet Safe?,2017-03-07 14:21:00 +0000,http://finance.yahoo.com/r/b1479b53-b27c-32cc-bd8a-13b69c902520/is-portola-pharmaceuticals-balance-sheet-safe.aspx?yptr=yahoo&.tsrc=rss,"Portola Pharmaceuticals has the cash necessary to launch promising drugs in its pipeline, now it just needs FDA approval."
PTLA,PTLA:UW,BBG004FJG6B0,Is Portola Pharmaceuticals Balance Sheet Safe?,2017-03-07 14:21:00 +0000,http://www.fool.com/investing/2017/03/07/is-portola-pharmaceuticals-balance-sheet-safe.aspx,Is Portola Pharmaceuticals Balance Sheet Safe?
PTLA,PTLA:UW,BBG004FJG6B0,"ETFs with exposure to Portola Pharmaceuticals, Inc. : March 6, 2017",2017-03-06 18:58:47 +0000,http://finance.yahoo.com/r/8d8c6e15-3ee5-3e2f-8102-9870c6cab02b/etfs-with-exposure-to-portola-pharmaceuticals-inc-march-6-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Portola Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PTLA-US. Comparing the performance and risk of Portola Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more    
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,"ETFs with exposure to Portola Pharmaceuticals, Inc. : March 6, 2017",2017-03-06 18:58:47 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-portola-pharmaceuticals-inc-march-6-2017/,"ETFs with exposure to Portola Pharmaceuticals, Inc. : March 6, 2017"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. :PTLA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017",2017-03-03 16:17:16 +0000,http://finance.yahoo.com/r/ba302bd0-abfc-326e-b57a-b7a07b8d31f7/portola-pharmaceuticals-inc-ptla-us-earnings-analysis-q4-2016-by-the-numbers-march-3-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Portola Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Portola Pharmaceuticals, Inc. – Johnson & Johnson, Biogen Inc., Sanofi Sponsored ADR, Bristol-Myers Squibb Company and Pfizer Inc. (JNJ-US, BIIB-US, SNY-US, BMY-US and PFE-US) that have also reported ... Read more    
<b>(Read more...)</b>"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. :PTLA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017",2017-03-03 16:17:16 +0000,http://www.capitalcube.com/blog/index.php/portola-pharmaceuticals-inc-ptla-us-earnings-analysis-q4-2016-by-the-numbers-march-3-2017/,"Portola Pharmaceuticals, Inc. :PTLA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017"
PTLA,PTLA:UW,BBG004FJG6B0,Top Biotech Stocks With FDA Decisions in 2017,2017-03-02 15:42:00 +0000,http://finance.yahoo.com/r/ff15c78e-b8a4-3cc8-95f3-d928326a20d1/top-biotech-stocks-with-fda-decisions-in-2017.aspx?yptr=yahoo&.tsrc=rss,"Flexion Therapeutics, Puma Biotechnology, and Portola Pharmaceuticals have important FDA decisions coming up this year."
PTLA,PTLA:UW,BBG004FJG6B0,Top Biotech Stocks With FDA Decisions in 2017,2017-03-02 15:42:00 +0000,http://www.fool.com/investing/2017/03/02/top-biotech-stocks-with-fda-decisions-in-2017.aspx,Top Biotech Stocks With FDA Decisions in 2017
PTLA,PTLA:UW,BBG004FJG6B0,"PORTOLA PHARMACEUTICALS INC Files SEC form 10-K, Annual Report",2017-03-01 22:19:28 +0000,http://biz.yahoo.com/e/170301/ptla10-k.html,"PORTOLA PHARMACEUTICALS INC Files SEC form 10-K, Annual Report"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences,2017-03-01 13:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-present-two-upcoming-130000801.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., March 01, 2017-- Portola Pharmaceuticals, Inc. ® today announced that Bill Lis, chief executive officer, will present at the following conferences in March:. Cowen and Company’ ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals to Present at Two Upcoming Investor Conferences,2017-03-01 13:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-present-two-upcoming-130000801.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., March 01, 2017-- Portola Pharmaceuticals, Inc. ® today announced that Bill Lis, chief executive officer, will present at the following conferences in March:. Cowen and Company’ ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals posts 4Q loss,2017-03-01 10:02:53 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-posts-4q-loss-100253923.html?.tsrc=rss,"On a per-share basis, the South San Francisco, California-based company said it had a loss of 95 cents. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals posts 4Q loss,2017-03-01 10:02:53 +0000,http://sg.finance.yahoo.com/news/portola-pharmaceuticals-posts-4q-loss-100253427.html,Portola Pharmaceuticals posts 4Q loss
PTLA,PTLA:UW,BBG004FJG6B0,Edited Transcript of PTLA earnings conference call or presentation 28-Feb-17 9:30pm GMT,2017-03-01 06:49:16 +0000,http://finance.yahoo.com/news/edited-transcript-ptla-earnings-conference-064916338.html?.tsrc=rss,Q4 2016 Portola Pharmaceuticals Inc Earnings Call
PTLA,PTLA:UW,BBG004FJG6B0,Edited Transcript of PTLA earnings conference call or presentation 28-Feb-17 9:30pm GMT,2017-03-01 06:49:16 +0000,http://finance.yahoo.com/news/edited-transcript-ptla-earnings-conference-064916338.html,Edited Transcript of PTLA earnings conference call or presentation 28-Feb-17 9:30pm GMT
PTLA,PTLA:UW,BBG004FJG6B0,Why Is Portola Pharmaceuticals Stock Red Hot in 2017?,2017-02-28 23:13:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WOc_W8--rps/why-is-portola-pharmaceuticals-stock-red-hot-in-2017-cm754563,Portola Pharmaceuticals NASDAQ PTLA 160 investors would probably like a mulligan on 2016 After the company experienced two painful setbacks to key programs shares lost 56 4 of their value last year Those losses 160 were tough to swallow but investors savvy enough to
PTLA,PTLA:UW,BBG004FJG6B0,Why Is Portola Pharmaceuticals Stock Red Hot in 2017?,2017-02-28 22:01:00 +0000,http://finance.yahoo.com/r/f0d5e3e5-d6f2-3aa5-a62d-2786b568d787/why-is-portola-pharmaceuticals-stock-red-hot-in-20.aspx?yptr=yahoo&.tsrc=rss,"After disappointing investors last year, shares in Portola Pharmaceuticals are surging higher on optimism for new drug launches."
PTLA,PTLA:UW,BBG004FJG6B0,Why Is Portola Pharmaceuticals Stock Red Hot in 2017?,2017-02-28 22:01:00 +0000,http://www.fool.com/investing/2017/02/28/why-is-portola-pharmaceuticals-stock-red-hot-in-20.aspx,Why Is Portola Pharmaceuticals Stock Red Hot in 2017?
PTLA,PTLA:UW,BBG004FJG6B0,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a",2017-02-28 21:56:14 +0000,http://biz.yahoo.com/e/170228/ptla8-k.html,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today,2017-02-28 21:30:00 +0000,http://biz.yahoo.com/cc/3/155803.html,Portola Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial Results and Provides Corporate Update,2017-02-28 21:05:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-reports-fourth-quarter-210500829.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Feb. 28, 2017-- Portola Pharmaceuticals, Inc. ® today provided a corporate update and reported its financial results for the fourth quarter and year ended December 31, 2016.. ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial Results and Provides Corporate Update,2017-02-28 21:05:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-reports-fourth-quarter-210500829.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Feb. 28, 2017-- Portola Pharmaceuticals, Inc. ® today provided a corporate update and reported its financial results for the fourth quarter and year ended December 31, 2016.. ..."
PTLA,PTLA:UW,BBG004FJG6B0,Q4 2016 Portola Pharmaceuticals Inc Earnings Release - After Market Close,2017-02-28 12:07:04 +0000,http://biz.yahoo.com/research/earncal/20170228.html?t=ptla,Q4 2016 Portola Pharmaceuticals Inc Earnings Release - After Market Close
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharma upgraded by Oppenheimer,2017-02-24 11:21:25 +0000,http://finance.yahoo.com/q/ud?s=PTLA,Portola Pharma upgraded by Oppenheimer
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Reaches Analyst Target Price,2017-02-22 15:51:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HBzu5WzgrR0/portola-pharmaceuticals-reaches-analyst-target-price-cm751215,In recent trading shares of Portola Pharmaceuticals Inc Symbol PTLA have crossed above the average analyst 12 month target price of 32 33 changing hands for 32 66 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Announce Fourth Quarter and Year-End 2016 Financial Results and Host Conference Call on Tuesday, February 28",2017-02-21 13:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-announce-fourth-quarter-130000954.html?.tsrc=rss,"SOUTH SAN FRANCISCO, Calif., Feb. 21, 2017-- Portola Pharmaceuticals, Inc. ® announced today that it will host a webcast and conference call to discuss the Company’ s financial results for the quarter ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Announce Fourth Quarter and Year-End 2016 Financial Results and Host Conference Call on Tuesday, February 28",2017-02-21 13:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-announce-fourth-quarter-130000954.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Feb. 21, 2017-- Portola Pharmaceuticals, Inc. ® announced today that it will host a webcast and conference call to discuss the Company’ s financial results for the quarter ..."
PTLA,PTLA:UW,BBG004FJG6B0,How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners,2017-02-16 17:55:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/coN6cS4qFbU/how-bristol-myers-squibb-and-pfizer-are-winning-a-big-brawl-in-blood-thinners-cm749029,Warfarin may have dominanted the 10 billion market for anticoagulants for the past 50 or so years but a new class of drugs that works in an entirely new way is quickly relegating warfarin s use to the dustbin Factor Xa inhibitors that keep blood clots from forming without
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Inc (PTLA) Just Scored Twice In Quick Succession,2017-02-09 15:11:26 +0000,http://finance.yahoo.com/r/b8ccd279-f9bb-33cb-b506-7259def49ace/portola-pharmaceuticals-inc-ptla-just-scored-twice-in-quick-succession-536799?yptr=yahoo&.tsrc=rss,"Portola Pharmaceuticals Inc (NASDAQ:PTLA) is riding high on the back of a couple of key announcements late this week. The company is up close to 10% on February, and more than 20% year to date. The most recent gains derive from two developments that – at first glance – seem somewhat unrelated, but which are […]"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Inc (PTLA) Just Scored Twice In Quick Succession,2017-02-09 15:11:26 +0000,http://www.insidermonkey.com/blog/portola-pharmaceuticals-inc-ptla-just-scored-twice-in-quick-succession-536799/,Portola Pharmaceuticals Inc (PTLA) Just Scored Twice In Quick Succession
PTLA,PTLA:UW,BBG004FJG6B0,"AGTC On Watch, It's Advantage REGN, No Need For FDA Panel Review For Betrixaban",2017-02-09 04:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/belLj8ylNro/agtc-on-watch-its-advantage-regn-no-need-for-fda-panel-review-for-betrixaban-20170209-00216,"AGTC On Watch, It's Advantage REGN, No Need For FDA Panel Review For Betrixaban"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Inks $150M Royalty Deal,2017-02-08 14:46:00 +0000,http://www.investopedia.com/news/portola-pharma-signs-150m-royalty-deal-ptla/?partner=YahooSA,Portola Pharmaceuticals Inks $150M Royalty Deal
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Inks $150M Royalty Deal,2017-02-08 14:46:00 +0000,http://finance.yahoo.com/r/2dc61fd7-008b-3c3e-87a1-4e0acf322e5e/portola-pharma-signs-150m-royalty-deal-ptla?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Portola got $150 million in exchange for future royalties from AndexXa, which currently is on hold."
PTLA,PTLA:UW,BBG004FJG6B0,FDA Informs Portola Pharmaceuticals at Mid-Cycle Review for Betrixaban That It Has Not Identified Issues that Require an Advisory Committee Meeting,2017-02-08 13:00:00 +0000,http://finance.yahoo.com/news/fda-informs-portola-pharmaceuticals-mid-130000672.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Feb. 08, 2017-- Portola Pharmaceuticals, Inc. ® today announced that the U.S. Food and Drug Administration’ s Center for Drug Evaluation and Research has informed the Company, ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Portola, HealthCare Royalty Partners Ink $150 Million Deal",2017-02-06 14:18:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fuj7zzZeASg/portola-healthcare-royalty-partners-ink-150-million-deal-cm743499,Portola Pharmaceuticals Inc s PTLA shares were up 2 7 after the company announced that it has signed a royalty agreement with HealthCare Royalty Partners HCR a private investment firm for 150 million A look at Portola s share price movement over the past one year shows that
PTLA,PTLA:UW,BBG004FJG6B0,"Portola, HealthCare Royalty Partners Ink $150 Million Deal",2017-02-06 13:19:01 +0000,http://finance.yahoo.com/news/portola-healthcare-royalty-partners-ink-131901640.html,"Portola, HealthCare Royalty Partners Ink $150 Million Deal"
PTLA,PTLA:UW,BBG004FJG6B0,"ESPR, MDCO Riding High, New Uses For MRK's Old Drug, DBVT In Full Smile(e)",2017-02-06 00:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EOS3Jpb0UZU/espr-mdco-riding-high-new-uses-for-mrks-old-drug-dbvt-in-full-smilee-20170206-00016,"ESPR, MDCO Riding High, New Uses For MRK's Old Drug, DBVT In Full Smile(e)"
PTLA,PTLA:UW,BBG004FJG6B0,"Premarket Biotech Movers: Portola, Esperion, Medicines",2017-02-03 14:32:00 +0000,https://www.thestreet.com/story/13977918/1/premarket-biotech-movers-portola-esperion-medicines.html?puc=yahoo&cm_ven=YAHOO,"Premarket Biotech Movers: Portola, Esperion, Medicines"
PTLA,PTLA:UW,BBG004FJG6B0,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E",2017-02-03 13:42:27 +0000,http://biz.yahoo.com/e/170203/ptla8-k.html,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Signs $150 Million Royalty Agreement with HealthCare Royalty Partners for Development and Commercialization of Andexanet Alfa,2017-02-03 13:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-signs-150-million-130000198.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Feb. 03, 2017-- Portola Pharmaceuticals, Inc. ® today announced that it has signed a $150 million royalty agreement with HealthCare Royalty Partners. Under the terms of the ..."
PTLA,PTLA:UW,BBG004FJG6B0,3 Biotech Stocks I'd Buy Right Now,2017-01-30 20:12:41 +0000,http://www.fool.com/investing/2017/01/29/3-biotech-stocks-id-buy-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotech Stocks I'd Buy Right Now
PTLA,PTLA:UW,BBG004FJG6B0,3 Biotech Stocks I'd Buy Right Now,2017-01-29 21:30:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gVzdPgzxHQg/3-biotech-stocks-id-buy-right-now-cm739905,Conflicting statements from the Trump administration have made owning biotech stocks feel like a roller coaster ride in recent weeks but there are a few stocks I d happily buy and hold despite the sway of political uncertainty Shares of Ligand Pharmaceuticals NASDAQ LGND
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Crashed 56.4% In 2016,2017-01-13 17:39:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZIgFmI-1sEo/why-portola-pharmaceuticals-crashed-564-in-2016-cm733369,Image source Getty Images What happened After releasing disappointing phase 3 data early last year and receiving a FDA rejection in August shares of Portola Pharmaceuticals NASDAQ PTLA lost 56 4 of their value in 2016 160 according to S amp P Global
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Crashed 56.4% In 2016,2017-01-13 15:41:06 +0000,http://www.fool.com/investing/2017/01/13/why-portola-pharmaceuticals-crashed-564-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Portola Pharmaceuticals Crashed 56.4% In 2016
PTLA,PTLA:UW,BBG004FJG6B0,"Biotech Premarket Movers: SGMO, IPXL, PTLA",2017-01-13 14:23:00 +0000,https://www.thestreet.com/story/13953596/1/biotech-premarket-movers-sgmo-ipxl-ptla.html?puc=yahoo&cm_ven=YAHOO,"Biotech Premarket Movers: SGMO, IPXL, PTLA"
PTLA,PTLA:UW,BBG004FJG6B0,3 Little-Known Pharmaceutical Companies to Put on Your Radar,2017-01-12 20:54:41 +0000,http://www.fool.com/investing/2017/01/11/3-little-known-pharmaceutical-companies-to-put-on.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Little-Known Pharmaceutical Companies to Put on Your Radar
PTLA,PTLA:UW,BBG004FJG6B0,3 Little-Known Pharmaceutical Companies to Put on Your Radar,2017-01-11 21:58:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eCiPoBQ-gb0/3-little-known-pharmaceutical-companies-to-put-on-your-radar-cm732433,Over the past year the best performing drugmaker stocks all have had one thing in common They received very little attention before providing patient investors windfall gains Being considered insignificant in itself isn t a great reason to scoop up shares of Teligent NASDAQ
PTLA,PTLA:UW,BBG004FJG6B0,2 Top Stocks in Biotech,2017-01-10 13:53:35 +0000,http://www.fool.com/investing/2017/01/09/2-top-stocks-in-biotech.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,2 Top Stocks in Biotech
PTLA,PTLA:UW,BBG004FJG6B0,Implied IYH Analyst Target Price: $169,2017-01-09 15:50:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LseEZMqsXr0/implied-iyh-analyst-target-price-169-cm730978,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
PTLA,PTLA:UW,BBG004FJG6B0,My Worst Predictions for Biotech in 2016,2017-01-03 22:41:09 +0000,http://www.fool.com/investing/2017/01/03/my-worst-predictions-for-biotech-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,My Worst Predictions for Biotech in 2016
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Webcast Corporate Update on January 10, 2017",2017-01-03 13:13:08 +0000,http://www.publicnow.com/view/84C6823FF6DD631B06F76F28322D9587BF62FFC8,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (Nasdaq:PTLA) today announced that it will host an investor webcast to review recent achievements and corporate ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Webcast Corporate Update on January 10, 2017",2017-01-03 13:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-webcast-corporate-january-130000761.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Jan. 03, 2017-- Portola Pharmaceuticals, Inc. ® today announced that it will host an investor webcast to review recent achievements and corporate and product milestones over ..."
PTLA,PTLA:UW,BBG004FJG6B0,[$$] Portola Pharmaceuticals' Pivotal Year,2016-12-28 18:34:00 +0000,http://www.barrons.com/articles/portola-pharmaceuticals-pivotal-year-1482868686?mod=yahoobarrons&ru=yahoo,[$$] Portola Pharmaceuticals' Pivotal Year
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up",2016-12-27 16:01:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1I0Qa_PZBpg/portola-betrixaban-accepted-for-review-in-us-eu-stock-up-cm726398,Shares of Portola Pharmaceuticals Inc PTLA surged 33 8 after the company s new drug application for its oral once daily Factor Xa inhibitor anticoagulant betrixaban was accepted under priority review by the FDA Note that Portola is looking to get betrixaban approved for extended
PTLA,PTLA:UW,BBG004FJG6B0,Biotech Poised for Rebound,2016-12-27 16:00:00 +0000,http://realmoney.thestreet.com/articles/12/27/2016/biotech-poised-rebound?puc=yahoo&cm_ven=YAHOO,Biotech Poised for Rebound
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up",2016-12-27 14:07:02 +0000,http://finance.yahoo.com/news/portola-betrixaban-accepted-review-u-140702838.html,"Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up"
PTLA,PTLA:UW,BBG004FJG6B0,"Why Portola Pharmaceuticals, Caesars Entertainment, and Cal-Maine Foods Jumped Today",2016-12-23 23:57:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BlOK377Xzt8/why-portola-pharmaceuticals-caesars-entertainment-and-cal-maine-foods-jumped-today-cm725909,This week has proven to be a disappointment for bullish investors who were hoping to see the Dow Jones Industrials reach a historic 20 000 milestone Friday brought slight gains to the overall stock market but they weren t enough to push the Dow into uncharted territory and
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Inc Stock Surged Higher Today,2016-12-23 23:57:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UcIyicNfP6o/why-portola-pharmaceuticals-inc-stock-surged-higher-today-cm725903,Image source Getty Images What happened Shares of clinical stage anticoagulant specialist Portola Pharmaceuticals Inc NASDAQ PTLA 160 rose 33 5 at the end of Friday s session 160 Announcements that key regulatory agencies have officially accepted new drug applications
PTLA,PTLA:UW,BBG004FJG6B0,"IONS Scripts History, PTLA Gets FDA Date, Strongbridge Slumps, NEOT On Watch",2016-12-23 22:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S7zA7XycUqc/ions-scripts-history-ptla-gets-fda-date-strongbridge-slumps-neot-on-watch-20161223-00490,"IONS Scripts History, PTLA Gets FDA Date, Strongbridge Slumps, NEOT On Watch"
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Inc Stock Surged Higher Today,2016-12-23 22:35:48 +0000,http://www.fool.com/investing/2016/12/23/why-portola-pharmaceuticals-is-up-27-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Portola Pharmaceuticals Inc Stock Surged Higher Today
PTLA,PTLA:UW,BBG004FJG6B0,"Why Portola Pharmaceuticals, Caesars Entertainment, and Cal-Maine Foods Jumped Today",2016-12-23 22:05:00 +0000,http://www.fool.com/investing/2016/12/23/why-portola-pharmaceuticals-caesars-entertainment.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Portola Pharmaceuticals, Caesars Entertainment, and Cal-Maine Foods Jumped Today"
PTLA,PTLA:UW,BBG004FJG6B0,"Notable Friday Option Activity: Z, PTLA, CMP",2016-12-23 21:57:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hq_rVTbrgSs/notable-friday-option-activity-z-ptla-cmp-cm725881,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Zillow Group Inc Symbol Z where a total volume of 12 753 contracts has been traded thus far today a contract volume which is representative of approximately 1 3
PTLA,PTLA:UW,BBG004FJG6B0,[$$] Portola Shares Surge on Application Acceptance,2016-12-23 20:18:58 +0000,http://www.wsj.com/articles/portola-shares-surge-on-application-acceptance-1482524336?mod=yahoo_hs,[$$] Portola Shares Surge on Application Acceptance
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals Announces FDA Accepts New Drug Application for Priority Review and EMA Validates Marketing Authorization Application for Oral, Factor Xa Inhibitor Anticoagulant Betrixaban",2016-12-23 19:28:09 +0000,http://www.publicnow.com/view/68EED19F62ACD7CFDCFD092C5D1D9F82D014FE3A,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Dec. 23, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (Nasdaq:PTLA) today announced that the U.S. Food and Drug Administration (FDA) accepted Portola's New Drug Application ..."
PTLA,PTLA:UW,BBG004FJG6B0,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an O",2016-12-22 21:07:42 +0000,http://biz.yahoo.com/e/161222/ptla8-k.html,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an O"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PTLA) : December 21, 2016",2016-12-21 14:56:41 +0000,http://www.capitalcube.com/blog/index.php/portola-pharmaceuticals-inc-value-analysis-nasdaqptla-december-21-2016/,"Portola Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PTLA) : December 21, 2016"
PTLA,PTLA:UW,BBG004FJG6B0,Bristol-Myers Squibb Co (BMY) And Pfizer Inc. (PFE) Agree To $50 Million Loan To Portola Pharmaceuticals Inc (PTLA),2016-12-20 15:36:13 +0000,http://www.insidermonkey.com/blog/bristol-myers-squibb-co-bmy-and-pfizer-inc-pfe-agree-to-50-million-loan-to-portola-pharmaceuticals-inc-ptla-512239/,Bristol-Myers Squibb Co (BMY) And Pfizer Inc. (PFE) Agree To $50 Million Loan To Portola Pharmaceuticals Inc (PTLA)
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PTLA-US : December 20, 2016",2016-12-20 12:20:25 +0000,http://www.capitalcube.com/blog/index.php/portola-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-ptla-us-december-20-2016/,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PTLA-US : December 20, 2016"
PTLA,PTLA:UW,BBG004FJG6B0,"CLVS Gets FDA Nod, PBYI Leaves Big Board, LOXO Hits All-time High, CNAT On Watch",2016-12-19 20:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9I2-LeJFKKM/clvs-gets-fda-nod-pbyi-leaves-big-board-loxo-hits-alltime-high-cnat-on-watch-20161219-01000,"CLVS Gets FDA Nod, PBYI Leaves Big Board, LOXO Hits All-time High, CNAT On Watch"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement,2016-12-19 17:20:55 +0000,http://finance.yahoo.com/news/portola-pharma-wins-pfizer-bristol-172055438.html,Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Enters into $50 Million Loan Agreement with Bristol-Myers Squibb and Pfizer for Continued Development of AndexXa™ (andexanet alfa),2016-12-19 13:11:09 +0000,http://www.publicnow.com/view/D59C92548A8CF5B186820809D8F37AFE73441401,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (Nasdaq:PTLA) today announced it has signed a $50 million loan agreement with Bristol-Myers Squibb Company (NYSE:BMY) ..."
PTLA,PTLA:UW,BBG004FJG6B0,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement",2016-12-15 22:18:27 +0000,http://biz.yahoo.com/e/161215/ptla8-k.html,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement"
PTLA,PTLA:UW,BBG004FJG6B0,From Hype To Flop: 10 Biotech Stops That Let Down Investors In 2016,2016-12-07 05:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vxgHkCpzlNM/from-hype-to-flop-10-biotech-stops-that-let-down-investors-in-2016-20161207-00107,From Hype To Flop: 10 Biotech Stops That Let Down Investors In 2016
PTLA,PTLA:UW,BBG004FJG6B0,Is Portola Pharmaceuticals Inc (PTLA) Worthy of Your Portfolio?,2016-12-06 16:10:44 +0000,http://www.insidermonkey.com/blog/is-portola-pharmaceuticals-inc-ptla-worthy-of-your-portfolio-498216/,Is Portola Pharmaceuticals Inc (PTLA) Worthy of Your Portfolio?
PTLA,PTLA:UW,BBG004FJG6B0,3 Small-Cap Biotech Stocks That Could Double in 2017,2016-12-02 20:46:41 +0000,http://www.fool.com/investing/2016/12/02/3-small-cap-biotech-stocks-that-could-double-in-20.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Small-Cap Biotech Stocks That Could Double in 2017
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals Announces AndexXa™ (andexanet alfa), Betrixaban and Cerdulatinib Data to be Presented at 2016 American Society of Hematology Annual Meeting and Exposition",2016-11-28 13:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-announces-andexxa-andexanet-130000039.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Nov. 28, 2016-- Portola Pharmaceuticals today announced that clinical and preclinical results from studies of all three of its investigational drugs-- AndexXa™, betrixaban ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Three Phase 3 APEX Substudy Results Showing Further Benefits of Treating Acute Medically Ill Patients with Extended-Duration Betrixaban,2016-11-14 21:47:07 +0000,http://www.publicnow.com/view/7A4FE694F936544E90FD101AEB4F07A82C9F3A30,"[at noodls] - NEW ORLEANS and SOUTH SAN FRANCISCO, Calif., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (Nasdaq:PTLA) today announced results from three substudies of the pivotal Phase 3 APEX Study ..."
PTLA,PTLA:UW,BBG004FJG6B0,Edited Transcript of PTLA earnings conference call or presentation 7-Nov-16 9:30pm GMT,2016-11-08 08:32:13 +0000,http://finance.yahoo.com/news/edited-transcript-ptla-earnings-conference-083213039.html,Edited Transcript of PTLA earnings conference call or presentation 7-Nov-16 9:30pm GMT
PTLA,PTLA:UW,BBG004FJG6B0,"MDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., It''s Time To Cherish IONS",2016-11-08 05:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M0DGzlGr9Js/mdco-tastes-bitter-prto-awaits-phase-3-data-in-dec-its-time-to-cherish-ions-20161108-00167,"MDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., It''s Time To Cherish IONS"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals posts 3Q loss,2016-11-07 23:06:47 +0000,http://sg.finance.yahoo.com/news/portola-pharmaceuticals-posts-3q-loss-230647968.html,Portola Pharmaceuticals posts 3Q loss
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today,2016-11-07 21:30:00 +0000,http://biz.yahoo.com/cc/5/154645.html,Portola Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
PTLA,PTLA:UW,BBG004FJG6B0,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a",2016-11-07 21:29:42 +0000,http://biz.yahoo.com/e/161107/ptla8-k.html,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update,2016-11-07 21:19:59 +0000,http://www.publicnow.com/view/70E8209565CB6F77C64D94224DAEE915D4B46FCA,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) today provided a corporate update and reported its financial results for the third quarter ended ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces New APEX Study Sub-Analyses Data to be Presented at American Heart Association Scientific Sessions 2016,2016-11-07 13:14:11 +0000,http://www.publicnow.com/view/C129739B8B545B2F8668BE07380DA2E4090C30D5,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (Nasdaq:PTLA) today announced that results of new sub-analyses of the Phase 3 APEX Study of betrixaban, conducted ..."
PTLA,PTLA:UW,BBG004FJG6B0,Q3 2016 Portola Pharmaceuticals Inc Earnings Release - After Market Close,2016-11-07 12:07:06 +0000,http://biz.yahoo.com/research/earncal/20161107.html?t=ptla,Q3 2016 Portola Pharmaceuticals Inc Earnings Release - After Market Close
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals to Present at the Credit Suisse 25th Annual Healthcare Conference,2016-11-02 12:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-present-credit-suisse-120000006.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Nov. 02, 2016-- Portola Pharmaceuticals today announced that Bill Lis, chief executive officer, will present at the Credit Suisse 24 th Annual Healthcare Conference on Tuesday, ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Expands Clinical Collaboration Agreement with Daiichi Sankyo Worth Up to $25 Million to Develop AndexXa™ (andexanet alfa) in Germany,2016-11-01 12:25:08 +0000,http://www.publicnow.com/view/6DC8BAFF3A139F5CCFCF52351F090659ADCD896B,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (Nasdaq:PTLA) today announced that it has expanded its existing clinical collaboration agreement with Daiichi ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals is Now Oversold,2016-10-31 22:13:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fn6w59C1Fm0/portola-pharmaceuticals-is-now-oversold-cm701396,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Announce Third Quarter 2016 Financial Results and Host Conference Call on Monday, November 7",2016-10-31 12:23:08 +0000,http://www.publicnow.com/view/E32C07DB02DE2CD0F4582408EE366BDF5191E32E,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (Nasdaq:PTLA) announced today that it will host a webcast and conference call to discuss the Company's financial ..."
PTLA,PTLA:UW,BBG004FJG6B0,"OGXI Up On Phase II Results, DPRX Falters On Missed Steps, LXRX Awaits Dec Data",2016-10-26 00:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cH9v1AOSuL8/ogxi-up-on-phase-ii-results-dprx-falters-on-missed-steps-lxrx-awaits-dec-data-20161026-00006,"OGXI Up On Phase II Results, DPRX Falters On Missed Steps, LXRX Awaits Dec Data"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Submits New Drug Application to U.S. FDA for Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism in Acute Medically Ill Patients,2016-10-25 12:21:04 +0000,http://www.publicnow.com/view/3A95B9B738994560E053A13D76DA4DFBD909C9C3,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (Nasdaq:PTLA) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Supports “World Thrombosis Day” Campaign to Increase Awareness of Risks of Blood Clots,2016-10-13 22:30:01 +0000,http://www.publicnow.com/view/54B4ADB6004E98D0762F2828B3F9167A71F7484C,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (Nasdaq:PTLA) is committed to raising awareness of the incidence, risks and potentially life-threatening complications ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Supports “World Thrombosis Day” Campaign to Increase Awareness of Risks of Blood Clots,2016-10-13 22:07:31 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-supports-world-thrombosis-220731626.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Oct. 13, 2016-- Portola Pharmaceuticals Inc. ® is committed to raising awareness of the incidence, risks and potentially life-threatening complications of thrombosis and is ..."
PTLA,PTLA:UW,BBG004FJG6B0,We Did The Math IYY Can Go To $118,2016-09-27 14:21:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nZ74uq3Ioxw/we-did-the-math-iyy-can-go-to-118-cm685289,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
PTLA,PTLA:UW,BBG004FJG6B0,3 Stocks That Could Make You Rich,2016-09-27 13:54:39 +0000,http://www.fool.com/investing/2016/09/26/3-stocks-that-could-make-you-rich.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks That Could Make You Rich
PTLA,PTLA:UW,BBG004FJG6B0,3 Stocks That Could Make You Rich,2016-09-26 15:24:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t2vXvMdSmzk/3-stocks-that-could-make-you-rich-cm684488,Image source Getty Images Trying to get rich quick is a great way to lose a lot of money in the stock market That said there are some stocks that could lead to pretty big gains in the near term Here are three favorites with upcoming catalysts that could propel their prices into
PTLA,PTLA:UW,BBG004FJG6B0,"Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks to Buy",2016-09-20 20:21:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YawhPysiZmE/forget-sarepta-therapeutics-here-are-3-other-biotech-stocks-to-buy-cm682236,Image source Stockmonkeys com via Flickr When the FDA approved 160 Sarepta Therapeutics NASDAQ SRPT controversial Duchenne muscular dystrophy drug Exondys 51 it caused shares in the company to surge 74 a market cap of 2 4 billion may fairly value it now If so
PTLA,PTLA:UW,BBG004FJG6B0,"Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks to Buy",2016-09-20 19:01:06 +0000,http://www.fool.com/investing/2016/09/20/forget-sarepta-therapeutics-here-are-3-other-biote.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks to Buy"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PTLA) : September 20, 2016",2016-09-20 15:57:58 +0000,http://www.capitalcube.com/blog/index.php/portola-pharmaceuticals-inc-value-analysis-nasdaqptla-september-20-2016/,"Portola Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PTLA) : September 20, 2016"
PTLA,PTLA:UW,BBG004FJG6B0,"After Losing Medivation, Who Is Gilead Going After Next?",2016-09-19 19:00:00 +0000,http://www.forbes.com/sites/kenkam/2016/09/19/who-is-gilead-about-to-buy/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"After Losing Medivation, Who Is Gilead Going After Next?"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PTLA-US : September 19, 2016",2016-09-19 12:12:33 +0000,http://www.capitalcube.com/blog/index.php/portola-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-ptla-us-september-19-2016/,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PTLA-US : September 19, 2016"
PTLA,PTLA:UW,BBG004FJG6B0,"Underlying Risks in Speculative Biotechs; Trump Speaks, Bonds Slide : Best of Kass",2016-09-17 01:00:00 +0000,https://www.thestreet.com/story/13743310/1/underlying-risks-in-speculative-biotechs-trump-speaks-bonds-slide-best-of-kass.html?puc=yahoo&cm_ven=YAHOO,"Underlying Risks in Speculative Biotechs; Trump Speaks, Bonds Slide : Best of Kass"
PTLA,PTLA:UW,BBG004FJG6B0,"ETF’s with exposure to Portola Pharmaceuticals, Inc. : September 13, 2016",2016-09-13 14:50:43 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-portola-pharmaceuticals-inc-september-13-2016/,"ETF’s with exposure to Portola Pharmaceuticals, Inc. : September 13, 2016"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Upcoming Data Presentations on AndexXa™ (andexanet alfa) at Neurocritical Care Society 2016 Annual Meeting,2016-09-13 12:28:02 +0000,http://www.publicnow.com/view/9F4FB5961035A5D5EE2EBA200A83EE0272AA349A,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Sept. 13, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (Nasdaq:PTLA) today announced that Phase 3 clinical data and preclinical data from studies of the Company's ..."
PTLA,PTLA:UW,BBG004FJG6B0,3 Biotech Stocks to Buy in September,2016-09-03 18:50:34 +0000,http://www.fool.com/investing/2016/09/02/3-biotech-stocks-to-buy-in-september.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotech Stocks to Buy in September
PTLA,PTLA:UW,BBG004FJG6B0,3 Biotech Stocks to Buy in September,2016-09-02 20:17:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6XPOFoMIIsc/3-biotech-stocks-to-buy-in-september-cm674298,Image source Getty Images The year 2016 is shaping up to be a rough 160 one for biotech investors The SPDR S amp P Biotech ETF an exchange traded fund that holds a wide variety of biotech stocks is down 160 13 year to date That badly lags the returns of the S amp P
PTLA,PTLA:UW,BBG004FJG6B0,What Gives With Portola Pharmaceuticals?,2016-08-31 20:35:02 +0000,http://www.fool.com/investing/2016/08/31/what-gives-with-portola-pharmaceuticals.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Gives With Portola Pharmaceuticals?
PTLA,PTLA:UW,BBG004FJG6B0,Here’s Why Smart Money Investors Are Betting on Portola Pharmaceuticals,2016-08-31 18:54:27 +0000,http://www.insidermonkey.com/blog/heres-why-smart-money-investors-are-betting-on-portola-pharmaceuticals-471307/,Here’s Why Smart Money Investors Are Betting on Portola Pharmaceuticals
PTLA,PTLA:UW,BBG004FJG6B0,What Gives With Portola Pharmaceuticals?,2016-08-31 15:12:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Eu5PACwt2WE/what-gives-with-portola-pharmaceuticals-cm672763,"A surprising FDA rejection of its most advanced drug candidate caused Portola Pharmaceuticals (NASDAQ  PTLA) shares to crater. What derailed Portola Pharmaceuticals' application for approval, and can this company get itself back on track?  In"
PTLA,PTLA:UW,BBG004FJG6B0,What's Up With Mylan's EpiPen Pricing?,2016-08-31 12:35:11 +0000,http://www.fool.com/investing/2016/08/30/whats-up-with-mylans-epipen-pricing.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What's Up With Mylan's EpiPen Pricing?
PTLA,PTLA:UW,BBG004FJG6B0,"CEMP To Face FDA Panel, RIGL On A High, FDA Nod For Erelzi, KPTI Awaits STORM",2016-08-31 01:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NgXcbz2q8oo/cemp-to-face-fda-panel-rigl-on-a-high-fda-nod-for-erelzi-kpti-awaits-storm-20160831-00024,"CEMP To Face FDA Panel, RIGL On A High, FDA Nod For Erelzi, KPTI Awaits STORM"
PTLA,PTLA:UW,BBG004FJG6B0,What's Up With Mylan's EpiPen Pricing?,2016-08-30 14:13:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9vAe9dR7J4k/whats-up-with-mylans-epipen-pricing-cm672070,"If you're diagnosed with a severe allergy that could lead to life threatening anaphylaxis, then you're probably carrying around one of Mylan N.V. 's(NASDAQ  MYL) EpiPens. Even if you don't own an EpiPen yourself, you've likely"
PTLA,PTLA:UW,BBG004FJG6B0,"Health Care Sector Update for 08/30/2016: PTLA, RIGL, JNJ, PFE, ABT, MRK, AMGN",2016-08-30 13:13:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JFmhtoWYltU/health-care-sector-update-for-08302016-ptla-rigl-jnj-pfe-abt-mrk-amgn-cm672041,"Top Health care stocks JNJ flat PFE flat ABT 1.1% MRK flat AMGN flat Health care shares were mostly unchanged in pre market trade Tuesday. In health care stocks news, Rigel Pharmaceuticals ( RIGL ) was up 5.3% as"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Interim Results from Ongoing Phase 3b/4 ANNEXXA-4™ Study of Factor Xa Inhibitor Antidote AndexXa™ (andexanet alfa) in Patients with Acute Major Bleeding,2016-08-30 08:33:04 +0000,http://www.publicnow.com/view/C301C354CE34772AE989C66C0A7EBFFF660EC91A,[at noodls] - --AndexXa Rapidly Reversed Anticoagulant Effect of Factor Xa Inhibitors; Excellent or Good Hemostasis Was Achieved in 79 Percent of Patients Over 12 Hours-- --Data Presented in Late-Breaking Science Hot ...
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Interim Results from Ongoing Phase 3b/4 ANNEXXA-4™ Study of Factor Xa Inhibitor Antidote AndexXa™ (andexanet alfa) in Patients with Acute Major Bleeding,2016-08-30 08:01:15 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-announces-interim-results-080115855.html,[GlobeNewswire] - --AndexXa Rapidly Reversed Anticoagulant Effect of Factor Xa Inhibitors; Excellent or Good Hemostasis Was Achieved in 79 Percent of Patients Over 12 Hours--. --Data Presented in Late-Breaking Science Hot ...
PTLA,PTLA:UW,BBG004FJG6B0,Biotech Stocks Facing FDA Decision In September,2016-08-30 03:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JLuJRoV-b_w/biotech-stocks-facing-fda-decision-in-september-20160830-00044,Biotech Stocks Facing FDA Decision In September
PTLA,PTLA:UW,BBG004FJG6B0,"Health Care Sector Update for 08/26/2016: PTLA,TGTX,ACOR",2016-08-26 18:25:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/us5RZcZmKyg/health-care-sector-update-for-08262016-ptlatgtxacor-cm670904,"Top Health Care Stocks JNJ +0.26% PFE +0.10% MRK +0.16% ABT +0.42% AMGN +0.69% Health care stocks were narrowly mixed Friday, with the NYSE Health Care Index dropping less than 0.1% while shares of health care companies in the"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Presentation of Interim Results from Phase 3b/4 ANNEXA™-4 Study of AndexXa™ (andexanet alfa) at European Society of Cardiology 2016 Congress,2016-08-26 12:28:06 +0000,http://www.publicnow.com/view/3C3FC46C0547BF6D30576CBF9A377A89411161D3,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Aug. 26, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (Nasdaq:PTLA) today announced that interim results from its ongoing Phase 3b/4 ANNEXA™-4 trial of AndexXa™ (andexanet ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Presentation of Interim Results from Phase 3b/4 ANNEXA™-4 Study of AndexXa™ (andexanet alfa) at European Society of Cardiology 2016 Congress,2016-08-26 12:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-announces-presentation-interim-120000067.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Aug. 26, 2016-- Portola Pharmaceuticals Inc. ® today announced that interim results from its ongoing Phase 3 b/4 ANNEXA™ -4 trial of AndexXa™, a Factor Xa inhibitor antidote, ..."
PTLA,PTLA:UW,BBG004FJG6B0,The Implied Analyst 12-Month Target For JKK,2016-08-25 13:46:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2qh9308lPjE/the-implied-analyst-12-month-target-for-jkk-cm669957,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
PTLA,PTLA:UW,BBG004FJG6B0,"Biotech Stock Roundup: Medivation to Pfizer, Clovis Priority Review",2016-08-24 18:09:06 +0000,http://finance.yahoo.com/news/biotech-stock-roundup-medivation-pfizer-180906503.html,"Biotech Stock Roundup: Medivation to Pfizer, Clovis Priority Review"
PTLA,PTLA:UW,BBG004FJG6B0,Portola IndexXa's Regulatory Application Validated in the EU,2016-08-22 13:48:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MNmD1uVXJGQ/portola-indexxas-regulatory-application-validated-in-the-eu-cm668297,"Portola Pharmaceuticals Inc.PTLA announced that the European Medicines Agency (EMA) has completed the validation period and accepted to review the company's Marketing Authorization Application (MAA) for IndexXa (andexanet alfa  U.S. trade name  AndexXa), a Factor"
PTLA,PTLA:UW,BBG004FJG6B0,Portola IndexXa's Regulatory Application Validated in the EU,2016-08-22 11:48:11 +0000,http://finance.yahoo.com/news/portola-indexxas-regulatory-application-validated-114811660.html,Portola IndexXa's Regulatory Application Validated in the EU
PTLA,PTLA:UW,BBG004FJG6B0,6 Companies That Destroyed Shareholders Last Week,2016-08-21 14:05:59 +0000,http://247wallst.com/investing/2016/08/21/6-companies-that-destroyed-shareholders-last-week-5/,6 Companies That Destroyed Shareholders Last Week
PTLA,PTLA:UW,BBG004FJG6B0,3 Stocks That Could Double Your Money,2016-08-21 13:44:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aTUmH4fwCXM/3-stocks-that-could-double-your-money-cm668169,"Image source  Getty Images.  It's uncommon for a company's stock to double in a relatively short period of time, but that doesn't mean it never happens. Sometimes Wall Street prices a company's stock"
PTLA,PTLA:UW,BBG004FJG6B0,3 Stocks That Could Double Your Money,2016-08-21 12:38:00 +0000,http://www.fool.com/investing/2016/08/21/3-stocks-that-could-double-your-money.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks That Could Double Your Money
PTLA,PTLA:UW,BBG004FJG6B0,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-08-19 21:32:08 +0000,http://biz.yahoo.com/e/160819/ptla8-k.html,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals (PTLA) Stock Falls, Citi Downgrades",2016-08-19 18:47:00 +0000,https://www.thestreet.com/story/13680542/1/portola-pharmaceuticals-ptla-stock-falls-citi-downgrades.html?puc=yahoo&cm_ven=YAHOO,"Portola Pharmaceuticals (PTLA) Stock Falls, Citi Downgrades"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola's AndexXa Still Approvable, But It Will Take Time",2016-08-19 15:45:30 +0000,http://finance.yahoo.com/news/portolas-andexxa-still-approvable-time-154530491.html,"Portola's AndexXa Still Approvable, But It Will Take Time"
PTLA,PTLA:UW,BBG004FJG6B0,"Citi Sees 'Too Much Risk' In Portola Pharma, Downgrades To Neutral",2016-08-19 14:06:28 +0000,http://finance.yahoo.com/news/citi-sees-too-much-risk-140628564.html,"Citi Sees 'Too Much Risk' In Portola Pharma, Downgrades To Neutral"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals Announces Validation of Marketing Authorization Application (MAA) by European Medicines Agency (EMA) for IndexXa™ (andexanet alfa), a Factor Xa Inhibitor Antidote",2016-08-19 13:01:02 +0000,http://www.publicnow.com/view/F061FBB81A0D7A7C6A5A948908B8095773DCE974,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Aug. 19, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (NASDAQ:PTLA) today announced that the MAA for IndexXa™ (andexanet alfa; trade name in the United States is AndexXa™), ..."
PTLA,PTLA:UW,BBG004FJG6B0,Is It &quot;Game Over&quot; After Portola's FDA Rejection?,2016-08-18 22:45:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6erSrWzjtyg/is-it-game-over-after-portolas-fda-rejection-cm667401,Image source  Getty Images.  Investors will have to wait to find out if Portola Pharmaceuticals '(NASDAQ  PTLA) first generation antidote to factor Xa anticoagulants will be as big of a hit as
PTLA,PTLA:UW,BBG004FJG6B0,"Is It ""Game Over"" After Portola's FDA Rejection?",2016-08-18 20:40:00 +0000,http://www.fool.com/investing/2016/08/18/is-it-game-over-after-portolas-fda-rejection.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Is It ""Game Over"" After Portola's FDA Rejection?"
PTLA,PTLA:UW,BBG004FJG6B0,RSI Alert: Portola Pharmaceuticals (PTLA) Now Oversold,2016-08-18 17:46:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xuv6OVoK6Io/rsi-alert-portola-pharmaceuticals-ptla-now-oversold-cm667233,"Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis"
PTLA,PTLA:UW,BBG004FJG6B0,Portola (PTLA) Stock Down on CRL for AndexXa BLA in U.S.,2016-08-18 16:48:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jWo7JlY_ScQ/portola-ptla-stock-down-on-crl-for-andexxa-bla-in-us-cm667190,Portola Pharmaceuticals Inc.PTLA shares lost almost 11% after the company announced that it has received a Complete Response Letter (CRL) from the FDA for its Biologics License Application (BLA) for AndexXa (andexanet alfa).  We note that
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals (PTLA) Stock Slumps on FDA Complete Response Letter,2016-08-18 16:05:00 +0000,https://www.thestreet.com/story/13679371/1/portola-pharmaceuticals-ptla-stock-slumps-on-fda-complete-response-letter.html?puc=yahoo&cm_ven=YAHOO,Portola Pharmaceuticals (PTLA) Stock Slumps on FDA Complete Response Letter
PTLA,PTLA:UW,BBG004FJG6B0,Thursday’s Top Health Care Stocks Punishing Investors,2016-08-18 15:50:22 +0000,http://247wallst.com/healthcare-business/2016/08/18/thursdays-top-health-care-stocks-punishing-investors/,Thursday’s Top Health Care Stocks Punishing Investors
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Inc (PTLA): A Misinterpretation Discount?,2016-08-18 15:21:28 +0000,http://www.insidermonkey.com/blog/portola-pharmaceuticals-inc-ptla-a-misinterpretation-discount-469618/,Portola Pharmaceuticals Inc (PTLA): A Misinterpretation Discount?
PTLA,PTLA:UW,BBG004FJG6B0,Why Portola Pharmaceuticals Inc Is Plunging Today,2016-08-18 15:06:00 +0000,http://www.fool.com/investing/2016/08/18/why-portola-pharmaceuticals-incs-is-plunging-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Portola Pharmaceuticals Inc Is Plunging Today
PTLA,PTLA:UW,BBG004FJG6B0,Managing Your Swing Positions/Trades Better,2016-08-18 14:38:28 +0000,http://finance.yahoo.com/tumblr/blog-managing-your-swing-positionstrades-better-143832161.html,Managing Your Swing Positions/Trades Better
PTLA,PTLA:UW,BBG004FJG6B0,Portola (PTLA) Stock Down on CRL for AndexXa BLA in U.S.,2016-08-18 14:16:02 +0000,http://finance.yahoo.com/news/portola-ptla-stock-down-crl-141602404.html,Portola (PTLA) Stock Down on CRL for AndexXa BLA in U.S.
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharma plummets 21% after government fails to accept new drug,2016-08-18 13:59:04 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=D99EB913-A4C7-4C00-8D0E-C492625C3AD9&siteid=yhoof2,Portola Pharma plummets 21% after government fails to accept new drug
PTLA,PTLA:UW,BBG004FJG6B0,"Pre-Market Most Active for Aug 18, 2016 :  SEMI, VRX, WMT, TLK, PTLA, AZN, TWTR, RPTP, CSIQ, CHK, BLDP, MOMO",2016-08-18 12:59:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qu4lAWyazas/pre-market-most-active-for-aug-18-2016-semi-vrx-wmt-tlk-ptla-azn-twtr-rptp-csiq-chk-bldp-momo-cm666982,"The NASDAQ 100 Pre Market Indicator is down 2.91 to 4,802.54. The total Pre Market volume is currently 6,747,583 shares traded. The following are the most active stocks for the pre market session SunEdison Semiconductor Limited ( SEMI )"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PTLA-US : August 18, 2016",2016-08-18 12:16:27 +0000,http://www.capitalcube.com/blog/index.php/portola-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-ptla-us-august-18-2016/,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PTLA-US : August 18, 2016"
PTLA,PTLA:UW,BBG004FJG6B0,Portola's AndexXa fails to get US FDA approval,2016-08-18 04:22:59 +0000,http://finance.yahoo.com/news/portolas-andexxa-fails-us-fda-042259671.html,[Reuters] - Portola Pharmaceuticals said on Wednesday its investigational drug AndexXa did not get approval from the U.S. Food and Drug Administration. AndexXa is being developed for patients being treated with a Factor Xa inhibitor when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. Factor Xa plays a key role in blood coagulation.
PTLA,PTLA:UW,BBG004FJG6B0,"JNP Will Bleed On Failed Trial, CERU Crashes, FDA Says No To PTLA",2016-08-18 03:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c-5q72dfmvo/jnp-will-bleed-on-failed-trial-ceru-crashes-fda-says-no-to-ptla-20160818-00064,"JNP Will Bleed On Failed Trial, CERU Crashes, FDA Says No To PTLA"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Receives Complete Response Letter from FDA for Biologics License Application for AndexXa™ (andexanet alfa),2016-08-18 03:21:06 +0000,http://www.publicnow.com/view/0439610925FE8AC3A7A2DEDF0AE1D93B8B037EAA,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Aug. 17, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (NASDAQ:PTLA) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Receives Complete Response Letter from FDA for Biologics License Application for AndexXa™ (andexanet alfa),2016-08-18 02:57:07 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-receives-complete-response-025707586.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Aug. 17, 2016-- Portola Pharmaceuticals Inc. ® today announced that it has received a Complete Response Letter from the U.S. Food and Drug Administration regarding its Biologics ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharma Receives CRL From FDA For BLA For AndexXa; Stock Plunges,2016-08-17 23:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YR1xG6wW03A/portola-pharma-receives-crl-from-fda-for-bla-for-andexxa-stock-plunges-20160817-00944,Portola Pharma Receives CRL From FDA For BLA For AndexXa; Stock Plunges
PTLA,PTLA:UW,BBG004FJG6B0,"ETF’s with exposure to Portola Pharmaceuticals, Inc. : August 15, 2016",2016-08-15 14:44:59 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-portola-pharmaceuticals-inc-august-15-2016/,"ETF’s with exposure to Portola Pharmaceuticals, Inc. : August 15, 2016"
PTLA,PTLA:UW,BBG004FJG6B0,"Mark Your Calendar For Aug.17, TRIL To Report Data In Q4, FLML Launches Akova",2016-08-14 23:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gve17BIXunc/mark-your-calendar-for-aug17-tril-to-report-data-in-q4-flml-launches-akova-20160814-00049,"Mark Your Calendar For Aug.17, TRIL To Report Data In Q4, FLML Launches Akova"
PTLA,PTLA:UW,BBG004FJG6B0,3 Under-the-Radar Healthcare Stocks You've Never Heard of,2016-08-13 14:37:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iWHlT7EFhno/3-under-the-radar-healthcare-stocks-youve-never-heard-of-cm665022,"When it comes to finding winning investments, it can pay off to travel the road less taken. Stocks that are household names are often priced at a premium  that means to find bargains in healthcare, you"
PTLA,PTLA:UW,BBG004FJG6B0,3 Under-the-Radar Healthcare Stocks You've Never Heard of,2016-08-13 13:00:00 +0000,http://www.fool.com/investing/2016/08/13/3-under-the-radar-healthcare-stocks-youve-never-he.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Under-the-Radar Healthcare Stocks You've Never Heard of
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. :PTLA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016",2016-08-12 14:25:02 +0000,http://www.capitalcube.com/blog/index.php/portola-pharmaceuticals-inc-ptla-us-earnings-analysis-q2-2016-by-the-numbers-august-12-2016/,"Portola Pharmaceuticals, Inc. :PTLA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals posts 2Q loss,2016-08-10 10:34:21 +0000,http://sg.finance.yahoo.com/news/portola-pharmaceuticals-posts-2q-loss-103421487.html,Portola Pharmaceuticals posts 2Q loss
PTLA,PTLA:UW,BBG004FJG6B0,Edited Transcript of PTLA earnings conference call or presentation 9-Aug-16 8:30pm GMT,2016-08-10 05:58:16 +0000,http://finance.yahoo.com/news/edited-transcript-ptla-earnings-conference-055816187.html,Edited Transcript of PTLA earnings conference call or presentation 9-Aug-16 8:30pm GMT
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today,2016-08-09 20:30:00 +0000,http://biz.yahoo.com/cc/1/153431.html,Portola Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
PTLA,PTLA:UW,BBG004FJG6B0,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a",2016-08-09 20:29:04 +0000,http://biz.yahoo.com/e/160809/ptla8-k.html,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update,2016-08-09 20:20:05 +0000,http://www.publicnow.com/view/378ED5AB9A570A3B1CA4FD87309C88D730E3C5D7,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (NASDAQ:PTLA) today provided a corporate update and reported its financial results for the quarter ended June ..."
PTLA,PTLA:UW,BBG004FJG6B0,Q2 2016 Portola Pharmaceuticals Inc Earnings Release - Time Not Supplied,2016-08-09 11:07:02 +0000,http://biz.yahoo.com/research/earncal/20160809.html?t=ptla,Q2 2016 Portola Pharmaceuticals Inc Earnings Release - Time Not Supplied
PTLA,PTLA:UW,BBG004FJG6B0,3 Troubled Pharma Stocks That Could Rally Soon,2016-08-09 03:19:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ski-z_CXIQc/3-troubled-pharma-stocks-that-could-rally-soon-cm662194,"Rocked by scandals and facing greater political scrutiny, the pharmaceutical industry faces one of its steepest challenges in recent memory. With a critical earnings test looming over the horizon, the"
PTLA,PTLA:UW,BBG004FJG6B0,3 Biotech Stocks to Buy in August,2016-08-07 04:16:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Flagezwb7Ns/3-biotech-stocks-to-buy-in-august-cm661488,"Image source  Getty Images.  It's been an awful year to be a biotech shareholder. The market cap weighted iShares Nasdaq Biotechnology ETF has bounced off some scary low points recently, but it's still"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Announce Second Quarter 2016 Financial Results and Host Conference Call on Tuesday, August 9",2016-08-02 20:32:14 +0000,http://www.publicnow.com/view/DF6B80FEF567E25E659586FBB3AE6A1E5E076B0C,"[at noodls] - SOUTH SAN FRANCISCO, Calif., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (Nasdaq:PTLA) announced today that it will host a webcast and conference call to discuss the Company's financial ..."
PTLA,PTLA:UW,BBG004FJG6B0,Biotech Stocks Facing FDA Decision In August,2016-07-29 00:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HhiN6pKzq7c/biotech-stocks-facing-fda-decision-in-august-20160729-00010,Biotech Stocks Facing FDA Decision In August
PTLA,PTLA:UW,BBG004FJG6B0,Biotech Stocks Facing FDA Decision In August,2016-07-29 00:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aJXqUlnyFow/biotech-stocks-facing-fda-decision-in-august-20160729-00011,Biotech Stocks Facing FDA Decision In August
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PTLA-US : July 27, 2016",2016-07-27 12:12:01 +0000,http://www.capitalcube.com/blog/index.php/portola-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-ptla-us-july-27-2016/,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PTLA-US : July 27, 2016"
PTLA,PTLA:UW,BBG004FJG6B0,Two Under The Radar Biotech Decisions To Watch Next Month,2016-07-25 18:29:45 +0000,http://www.insidermonkey.com/blog/two-under-the-radar-biotech-decisions-to-watch-next-month-466403/,Two Under The Radar Biotech Decisions To Watch Next Month
PTLA,PTLA:UW,BBG004FJG6B0,These 3 Biotechs Have Automatic Demand,2016-07-23 16:09:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/htNAc611718/these-3-biotechs-have-automatic-demand-cm653738,"It takes real skill to market a drug or medical device properly, and sales can greatly suffer if a company doesn't do it right. A marketing miscue can turn even the best drug or medical device into"
PTLA,PTLA:UW,BBG004FJG6B0,These 3 Biotechs Have Automatic Demand,2016-07-23 14:41:00 +0000,http://www.fool.com/investing/2016/07/23/these-3-biotechs-have-automatic-demand.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 3 Biotechs Have Automatic Demand
PTLA,PTLA:UW,BBG004FJG6B0,Six Major Biotech Acquisitions You Could See in 2016 (Part 2),2016-07-22 16:13:00 +0000,http://www.forbes.com/sites/kenkam/2016/07/22/six-major-biotech-acquisitions-you-could-see-in-2016-part-2-of-3/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Six Major Biotech Acquisitions You Could See in 2016 (Part 2)
PTLA,PTLA:UW,BBG004FJG6B0,PTLA March 2017 Options Begin Trading,2016-07-18 17:09:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5-PZk3eXgbo/ptla-march-2017-options-begin-trading-cm650653,"Investors in Portola Pharmaceuticals, Inc. (Symbol PTLA) saw new options become available today, for the March 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time"
PTLA,PTLA:UW,BBG004FJG6B0,3 Stocks to Buy Near Their 52-Week Lows,2016-07-11 18:49:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ipQoMBf3vM/3-stocks-to-buy-near-their-52-week-lows-cm647349,"Image source  Getty Images.  Great companies often go on sale, and when they do, investors can take advantage of discount prices. We asked some of our top contributors to dig through their wish"
PTLA,PTLA:UW,BBG004FJG6B0,3 Stocks to Buy Near Their 52-Week Lows,2016-07-11 17:27:00 +0000,http://www.fool.com/investing/2016/07/11/3-stocks-to-buy-near-their-52-week-lows.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks to Buy Near Their 52-Week Lows
PTLA,PTLA:UW,BBG004FJG6B0,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders",2016-06-22 20:20:51 +0000,http://biz.yahoo.com/e/160622/ptla8-k.html,"PORTOLA PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders"
PTLA,PTLA:UW,BBG004FJG6B0,These 5 Biotech Stocks Are Ridiculously Cheap,2016-06-21 20:05:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MC7PEJRZO94/these-5-biotech-stocks-are-ridiculously-cheap-cm638227,"Image source  Getty Images.  The biotechnology Industry has been beaten up pretty badly over the past year. Less than encouraging news from Gilead Sciences (NASDAQ  GILD) , Ionis Pharmaceuticals (NASDAQ  IONS)"
PTLA,PTLA:UW,BBG004FJG6B0,These 5 Biotech Stocks Are Ridiculously Cheap,2016-06-21 12:03:00 +0000,http://www.fool.com/investing/2016/06/21/these-5-biotech-stocks-are-ridiculously-cheap.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 5 Biotech Stocks Are Ridiculously Cheap
PTLA,PTLA:UW,BBG004FJG6B0,"ETF’s with exposure to Portola Pharmaceuticals, Inc. : June 20, 2016",2016-06-20 19:06:11 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-portola-pharmaceuticals-inc-june-20-2016/,"ETF’s with exposure to Portola Pharmaceuticals, Inc. : June 20, 2016"
PTLA,PTLA:UW,BBG004FJG6B0,"Commit To Purchase Portola Pharmaceuticals At $17.50, Earn 19.8% Annualized Using Options",2016-06-20 16:08:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/53lY8krcxRk/commit-to-purchase-portola-pharmaceuticals-at-1750-earn-198-annualized-using-options-cm637849,"Investors considering a purchase of Portola Pharmaceuticals, Inc. (Symbol PTLA) stock, but cautious about paying the going market price of $24.43 share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PTLA-US : June 17, 2016",2016-06-17 12:22:11 +0000,http://www.capitalcube.com/blog/index.php/portola-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-ptla-us-june-17-2016/,"Portola Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PTLA-US : June 17, 2016"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Dosing of First Patient in Phase 2a Study of Cerdulatinib for Treatment of Hematologic Cancer and Upcoming Presentations of New Phase 1 Clinical Data at ASCO and EHA Annual Meetings,2016-06-01 12:13:04 +0000,http://www.publicnow.com/view/CE3C95630C5DA3781AAAAACD22AE18CD94549B1E,"[at noodls] - SOUTH SAN FRANCISCO, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (NASDAQ:PTLA), today announced that it recently dosed the first patient in a Phase 2a study that is evaluating ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare Conference,2016-05-31 20:23:06 +0000,http://www.publicnow.com/view/670F819A4B7F854D2D9187344156E52537B32834,"[at noodls] - SOUTH SAN FRANCISCO, Calif., May 31, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced that Bill Lis, chief executive officer, will present at the Goldman Sachs 37 Annual Healthcare ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals: Does New Data Get It Back on Track?,2016-05-28 15:07:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KrpHhxwJMGY/portola-pharmaceuticals-does-new-data-get-it-back-on-track-cm627860,"Image source  Portola Pharmaceuticals.  After a mixed bag of trial results for its clinical stage anticoagulant caused shares to tumble back in March, Portola Pharmaceuticals (NASDAQ  PTLA) has offered up additional data"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thrombosis and Haemostasis (ISTH) Meeting,2016-05-27 12:57:03 +0000,http://www.publicnow.com/view/615CE0AB955081130786B9172E26D1A26D31C202,"[at noodls] - --Company Plans to Submit NDA and MAA for Betrixaban in Second Half of 2016-- --Webcast with APEX Study Executive Committee Members Today at 11 a.m. ET-- MONTPELLIER, France, and SOUTH SAN FRANCISCO, Calif. ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and AndexXa™ (andexanet alfa) at International Society on Thrombosis and Haemostasis (ISTH) 2016 Scientific and Standardization Committee Meeting,2016-05-23 12:16:09 +0000,http://www.publicnow.com/view/73C2EB2B108780DA701F243A5B9220CEC30DDE4D,"[at noodls] - SOUTH SAN FRANCISCO, Calif., May 23, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (NASDAQ:PTLA) today announced that the full data set from the Phase 3 APEX Study of betrixaban will be featured ..."
PTLA,PTLA:UW,BBG004FJG6B0,"VXF, LBTYA, ALX, PTLA: ETF Outflow Alert",2016-05-10 15:27:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SN0bmqGFQUI/vxf-lbtya-alx-ptla-etf-outflow-alert-cm618996,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the Vanguard Extended Market ETF (Symbol VXF) where we have detected an approximate $149.7 million dollar outflow"
PTLA,PTLA:UW,BBG004FJG6B0,"Monday's ETF Movers: XBI, XME",2016-05-09 17:16:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wOK2DM1Dp8o/mondays-etf-movers-xbi-xme-cm618361,"In trading on Monday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 3.1% on the day. Components of that ETF showing particular strength include shares of Eagle Pharmaceuticals, up about 20.1% and shares of Portola"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals posts 1Q loss,2016-05-05 21:35:43 +0000,http://sg.finance.yahoo.com/news/portola-pharmaceuticals-posts-1q-loss-213543548.html,Portola Pharmaceuticals posts 1Q loss
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update,2016-05-05 20:21:30 +0000,http://www.publicnow.com/view/8790B9DA638168E4F7B52A90742060A6AE254184,"[at noodls] - SOUTH SAN FRANCISCO, Calif., May 05, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. (NASDAQ:PTLA), today provided a corporate update and reported its financial results for the first quarter ended ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Announce First Quarter 2016 Financial Results and Host Conference Call on Thursday, May 5",2016-04-28 12:19:16 +0000,http://www.publicnow.com/view/B6EECBB02383484194A32AC15C56C12EFE5A286D,"[at noodls] - SOUTH SAN FRANCISCO, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (Nasdaq:PTLA) announced today that it will host a webcast and conference call to discuss the Company's financial ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Upcoming Cerdulatinib Data Presentation at American Association for Cancer Research (AACR) Annual Meeting 2016,2016-04-14 12:29:31 +0000,http://www.publicnow.com/view/B3B6CA213EB3E078A1AA496604611D5B0F0CAC59,"[at noodls] - SOUTH SAN FRANCISCO, Calif., April 14, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced that new data from a pharmacokinetic modeling study designed to identify the dose of ..."
PTLA,PTLA:UW,BBG004FJG6B0,3 Biotech Takeover Targets That Could Get Bought Soon,2016-04-13 21:04:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qUCpa6apm4g/3-biotech-takeover-targets-that-could-get-bought-soon-cm606011,"SOURCE  FLICKR USER ELLIOTT BROWN  Biotech stocks have been especially hard hit over the past six months because of concerns over drug prices, and the sell off within the industry has"
PTLA,PTLA:UW,BBG004FJG6B0,What Made Portola Pharmaceuticals Shares Collapse 33% in March,2016-04-12 23:01:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AUru1maSG1Q/what-made-portola-pharmaceuticals-shares-collapse-33-in-march-cm605499,"IMAGE SOURCE  PORTOLA PHARMACEUTICALS.  What   After reporting confusing and arguably mixed results from a late stage study, shares of Portola Pharmaceuticals   lost roughly a third of their value last"
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals Announces Presentation of Phase 3 APEX Study Results at International Society on Thrombosis and Haemostasis (ISTH) SSC Meeting 2016 on May 27, 2016",2016-04-06 12:10:05 +0000,http://www.publicnow.com/view/36B9F8E5A2D3D1AFBD39036EB11D15E8AB9279C1,"[at noodls] - SOUTH SAN FRANCISCO, Calif., April 06, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced that data from its Phase 3 APEX Study of betrixaban will be presented at the International ..."
PTLA,PTLA:UW,BBG004FJG6B0,Are Portola Pharmaceuticals' Hopes Dashed? Maybe Not.,2016-04-05 14:04:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eh_0mKKy_xA/are-portola-pharmaceuticals-hopes-dashed-maybe-not-cm601718,"After Portola Pharmaceuticals reported mixed results recently from a phase 3 trial of a key drug, its share price tumbled. However, Betrixaban's late stage study data may not spell the end to the drug's chances at"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement with Daiichi Sankyo to Develop Andexanet Alfa with Edoxaban in Japan,2016-04-04 12:17:24 +0000,http://www.publicnow.com/view/4D50D72470BB72D900C88F0E5112989D9F318F3E,"[at noodls] - SOUTH SAN FRANCISCO, Calif., April 04, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (NASDAQ:PTLA), announced today that it has entered into a clinical collaboration agreement with Daiichi Sankyo to ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Patent Palooza: One Patent Battle in Hep C, And Another Patent Brawl Brewing On Capitol Hill",2016-04-03 20:58:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rfv8OfwzXgw/patent-palooza-one-patent-battle-in-hep-c-and-another-patent-brawl-brewing-on-capitol-hill-cm601003,"Patent risk is one of the biggest risks in biotech, but patent risk isn't limited to the just patent expiration . Other patent risks can also cause revenue to slip or a company's shares to drop. For"
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Topline Results from Phase 3 APEX Trial of Betrixaban for Prevention of Blood Clots in Acute Medically Ill Patients,2016-03-24 11:23:34 +0000,http://www.publicnow.com/view/73C6D89317E8360C9FA91835FB10E99BF9EBC2AB,"[at noodls] - -Full Data Set to be Presented at International Society of Thrombosis and Haemostasis (ISTH) Congress in May- -Company to Hold Conference Call Today at 8:30 am ET- SOUTH SAN FRANCISCO, Calif., March 24, ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Hold Conference Call on Thursday, March 24, at 8:30 am ET",2016-03-24 08:22:24 +0000,http://www.publicnow.com/view/95D6E75A45CA5D4AF43076B91EC053D9F5301BEC,"[at noodls] - SOUTH SAN FRANCISCO, Calif., March 24, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (Nasdaq:PTLA) announced that it will host a conference call today, Thursday, March 24, 2016, at 8:30 a.m. Eastern ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals posts 4Q loss,2016-02-26 10:33:23 +0000,http://sg.finance.yahoo.com/news/portola-pharmaceuticals-posts-4q-loss-103323908.html,Portola Pharmaceuticals posts 4Q loss
PTLA,PTLA:UW,BBG004FJG6B0,Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan,2016-02-01 12:30:29 +0000,http://www.publicnow.com/view/F7660153E3487598EBF451FB45A30940B58F2AC8,"[at noodls] - PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NSYE:PFE) today announced that the companies have entered into a collaboration agreement with Portola ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Enters Into Licensing Agreements for Investigational Agent Andexanet Alfa in Japan Worth Up to $120 Million,2016-02-01 12:10:15 +0000,http://www.publicnow.com/view/758CD38F05CB9BB73E38CFA08D9190800B3A6B07,"[at noodls] - , (GLOBE NEWSWIRE) -- (NASDAQ:PTLA), announced today that it has licensed lead development and commercial rights to its investigational agent andexanet alfa in to and to be developed as an antidote for ..."
PTLA,PTLA:UW,BBG004FJG6B0,"Portola Pharmaceuticals to Webcast Corporate Update on January 12, 2016",2016-01-08 13:15:56 +0000,http://www.noodls.com/view/A415D972EE9C6BAE69C6CF3F46A38DF556D2C75E,"[at noodls] - , (GLOBE NEWSWIRE) -- (Nasdaq:PTLA) today announced that it will host an investor webcast to review its recent achievements and corporate and product milestones over the next year. The webcast, which will ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Completes BLA Submission to U.S. Food and Drug Administration for Andexanet Alfa,2015-12-18 13:12:20 +0000,http://www.noodls.com/view/4ACAB181DD34B2A8C6476BE6A2383A942D24E29F,"[at noodls] - , (GLOBE NEWSWIRE) -- (Nasdaq:PTLA) announced today completion of the submission of a Biologics License Application (BLA) to the () for its investigational agent andexanet alfa, an -designated breakthrough ..."
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals Announces Andexanet Alfa and Cerdulatinib Data Presentations at the 2015 American Society of Hematology Annual Meeting and Exposition,2015-12-05 13:26:16 +0000,http://www.noodls.com/view/509607FB36F635DC07B5F653E137E5A24B4B4FD5,[at noodls] - Portola Pharmaceuticals Announces Andexanet Alfa and Cerdulatinib Data Presentations at the 2015 American Society of Hematology Annual Meeting and Exposition
PTLA,PTLA:UW,BBG004FJG6B0,Portola Announces Pricing of Public Offering of Common Stock,2015-12-04 13:08:16 +0000,http://www.noodls.com/view/DF4C007DD28D79ED42859DC70AA57483F1ABDF74,[at noodls] - Portola Announces Pricing of Public Offering of Common Stock
PTLA,PTLA:UW,BBG004FJG6B0,Portola Pharmaceuticals posts 3Q loss,2015-11-10 00:05:57 +0000,http://sg.finance.yahoo.com/news/portola-pharmaceuticals-posts-3q-loss-000557634.html,Portola Pharmaceuticals posts 3Q loss
